<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31481879</article-id>
<article-id pub-id-type="pmc">6710438</article-id>
<article-id pub-id-type="doi">10.3389/fncel.2019.00385</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic Causes and Modifiers of Autism Spectrum Disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rylaarsdam</surname>
<given-names>Lauren</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/751339/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guemez-Gamboa</surname>
<given-names>Alicia</given-names>
</name>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/683777/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff><institution>Department of Physiology, Feinberg School of Medicine, Northwestern University</institution>, <addr-line>Chicago, IL</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: João Peça, University of Coimbra, Portugal</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Santhosh Girirajan, The Pennsylvania State University, United States; Chihiro Sato, Nagoya University, Japan</p>
</fn>
<corresp id="c001">*Correspondence: Alicia Guemez-Gamboa, <email>alicia.guemez@northwestern.edu</email></corresp>
<fn fn-type="other" id="fn004">
<p>This article was submitted to Cellular Neuropathology, a section of the journal Frontiers in Cellular Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>13</volume>
<elocation-id>385</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>8</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Rylaarsdam and Guemez-Gamboa.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Rylaarsdam and Guemez-Gamboa</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Autism Spectrum Disorder (ASD) is one of the most prevalent neurodevelopmental disorders, affecting an estimated 1 in 59 children. ASD is highly genetically heterogeneous and may be caused by both inheritable and <italic>de novo</italic> gene variations. In the past decade, hundreds of genes have been identified that contribute to the serious deficits in communication, social cognition, and behavior that patients often experience. However, these only account for 10–20% of ASD cases, and patients with similar pathogenic variants may be diagnosed on very different levels of the spectrum. In this review, we will describe the genetic landscape of ASD and discuss how genetic modifiers such as copy number variation, single nucleotide polymorphisms, and epigenetic alterations likely play a key role in modulating the phenotypic spectrum of ASD patients. We also consider how genetic modifiers can alter convergent signaling pathways and lead to impaired neural circuitry formation. Lastly, we review sex-linked modifiers and clinical implications. Further understanding of these mechanisms is crucial for both comprehending ASD and for developing novel therapies.</p>
</abstract>
<kwd-group>
<kwd>autism spectrum disorder</kwd>
<kwd>genetic modifiers</kwd>
<kwd>CNV</kwd>
<kwd>epigenetics</kwd>
<kwd>gene-environment interaction</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="218"></ref-count>
<page-count count="15"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>Autism was first described by <xref ref-type="bibr" rid="B87">Kanner (1943)</xref> in a detailed report of 11 children with similar unusual tendencies. Intriguing common symptoms such as improper facilitation of language, indifference to other people, and obsessive interests can clearly be discerned while reading Kanner’s thorough patient history. Twenty-three years later, the first epidemiological study of autism estimated prevalence to be 4.5 per 10,000 individuals. Estimates have since increased drastically to 1 in 59 individuals affected, with at least three times as many males diagnosed as females (<xref ref-type="bibr" rid="B116">Loomes et al., 2017</xref>). This significant increase in prevalence is partially attributable to both increase in awareness and evolvement of Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria, from a childhood form of schizophrenia in 1952, to a core diagnosis covering a spectrum of disorders in the present (<xref ref-type="bibr" rid="B214">Zeldovich, 2018</xref>). The changing landscape of factors required for diagnosis makes it difficult to quantify the actual increase in prevalence.</p>
<p>According to the current DSM-5 criteria, only two core features make up an autism spectrum disorder (ASD) diagnosis: (1) persistent deficits in social communication and social interaction across multiple contexts; and (2) restricted, repetitive patterns of behavior, interests, or activities (<xref ref-type="bibr" rid="B105">Lai et al., 2014</xref>). Because of the broad nature of these definitions, an ASD diagnosis often co-occurs with other conditions. Motor abnormalities (79%), gastrointestinal problems (up to 70%), epilepsy (up to 30%), intellectual disability (45%), and sleep disorders (50–80%) are common examples (<xref ref-type="bibr" rid="B105">Lai et al., 2014</xref>). Language disorders are frequently co-occurring and were even included in the DSM-IV criteria.</p>
<p>Since autism’s identification as a diagnosis, the medical and scientific community have put immense effort into determining the risk factors and etiology. In Kanner’s original assessment, he makes the unfortunate observation that in addition to patients having highly intelligent parents, “One other fact stands out prominently. In the whole group, there are very few really warm-hearted fathers and mothers” (<xref ref-type="bibr" rid="B87">Kanner, 1943</xref>). Thankfully, this “Refrigerator Mother” theory of autism was quickly disproved. ASD is now understood to be a disease of complex interaction between genetics and the environment, with heritability estimates ranging from 40 to 80% (<xref ref-type="bibr" rid="B26">Chaste and Leboyer, 2012</xref>). Extensive genetic studies have revealed hundreds of genes linked to autism. Epidemiological investigations have begun to elucidate which environmental factors might be contributing to risk, but there is a lot left to understand about how they interact with genetic predisposition to contribute to ASD etiology.</p>
<p>As is often the case with complex diseases, individuals with similar pathogenic variants may have drastically varying phenotypes. For example, people with duplications of proximal 15q range from unaffected to severely disabled (<xref ref-type="bibr" rid="B31">Cook et al., 1997</xref>; <xref ref-type="bibr" rid="B16">Bolton et al., 2001</xref>). Genetic modifiers – factors that modulate the expression of other genes – likely exist when individuals with the same pathogenic variant present on opposite ends of the spectrum. In this review, we will discuss what is presently known about the genetic landscape of ASD, then look at potential modifiers including copy number variation (CNV), double-hit mutations, epigenetic influences, and sex-linked effects.</p>
</sec>
<sec id="S2">
<title>Genetics of ASD</title>
<sec id="S2.SS1">
<title>Identification of Candidate ASD Risk Genes</title>
<p>Following the classification of autism by Kanner, research efforts were undertaken to determine the disease etiology. Though it was initially assumed to be of environmental origin, an improved understanding of the role of genetics in human health soon suggested otherwise. In 1977, <xref ref-type="bibr" rid="B48">Folstein and Rutter (1977)</xref> conducted twin studies upon the observation that incidence among siblings was 50× higher than average. They found that monozygotic twins were more likely to share a diagnosis than dizygotic twins, suggesting a genetic influence. <xref ref-type="bibr" rid="B8">Bailey et al. (1995)</xref> supported this finding, documenting 60% concordance for monozygotic twins versus no concordant dizygotic pairs. In addition, risk of a child having ASD was found to be proportional to the percentage of the genome they shared with an affected sibling or parent (<xref ref-type="bibr" rid="B30">Constantino et al., 2010</xref>; <xref ref-type="bibr" rid="B156">Risch et al., 2014</xref>; <xref ref-type="bibr" rid="B164">Sandin et al., 2014</xref>). By the turn of the century, ASD was established to have some genetic component, though which genes were involved remained a mystery.</p>
<p>Early karyotype studies documenting chromosomal abnormalities began to shed light on which regions of the genome were involved (<xref ref-type="bibr" rid="B54">Gillberg and Wahlström, 1985</xref>). Additional susceptibility loci screens implicated regions on chromosome 7q, 1p, 3q, 16p, and 15q (<xref ref-type="bibr" rid="B74">IMGSAC, 1998</xref>; <xref ref-type="bibr" rid="B12">Barrett et al., 1999</xref>; <xref ref-type="bibr" rid="B21">Buxbaum et al., 2001</xref>; <xref ref-type="bibr" rid="B75">International Molecular Genetic Study of Autism Consortium [IMGSAC], 2001</xref>; <xref ref-type="bibr" rid="B112">Liu et al., 2001</xref>; <xref ref-type="bibr" rid="B6">Auranen et al., 2002</xref>; <xref ref-type="bibr" rid="B106">Lamb et al., 2002</xref>; <xref ref-type="bibr" rid="B173">Shao et al., 2003</xref>; <xref ref-type="bibr" rid="B156">Risch et al., 2014</xref>). However, to investigate at gene-level resolution, early studies had to use the candidate approach. Hypothesized targets included genes from suspected chromosomal regions that played a critical role in neurodevelopment, such as homeobox (<italic>Hox</italic>) family or <italic>Wnt</italic> genes. Unsurprisingly, many early studies using this method were largely inconclusive (<xref ref-type="bibr" rid="B99">Krebs et al., 2002</xref>; <xref ref-type="bibr" rid="B106">Lamb et al., 2002</xref>; <xref ref-type="bibr" rid="B189">Talebizadeh et al., 2002</xref>; <xref ref-type="bibr" rid="B215">Zhang et al., 2002</xref>). Starting in 2001, the candidate approach experienced moderate success with findings supporting reelin (<italic>RELN</italic>), aristaless related homeobox (<italic>Arx</italic>), methyl-CpG binding protein 2 (<italic>MeCP2</italic>), neuroligin 3 (<italic>NLGN3</italic>), neuroligin 4 (<italic>NLGN4</italic>), tuberous sclerosis complex 2 (<italic>TSC2</italic>), and ubiquitin protein ligase E3A (<italic>UBE3A</italic>)’s involvement in ASD etiology (<xref ref-type="bibr" rid="B139">Persico et al., 2001</xref>; <xref ref-type="bibr" rid="B184">Strømme et al., 2002</xref>; <xref ref-type="bibr" rid="B22">Carney et al., 2003</xref>; <xref ref-type="bibr" rid="B81">Jamain et al., 2003</xref>; <xref ref-type="bibr" rid="B172">Serajee et al., 2003</xref>; <xref ref-type="bibr" rid="B83">Jiang et al., 2004</xref>).</p>
<p>In the early 2000s, the advent of high throughput sequencing revolutionized genetic research and enabled investigators to study ASD on a genome-wide level. Sequencing technology quickly confirmed that the etiology of ASD was multigenic and highly heterogeneous, with very few of the same pathogenic variants present in a significant percentage of afflicted individuals. It is now known that the average case is a product of many susceptibility-increasing variations. Only a handful of ASD-related diseases have monogenic causes, such as Rett syndrome, fragile X syndrome, tuberous sclerosis, and Schuurs–Hoeijmakers syndrome (<xref ref-type="bibr" rid="B5">Artuso et al., 2011</xref>; <xref ref-type="bibr" rid="B181">Stern et al., 2017</xref>; <xref ref-type="bibr" rid="B209">Woodbury-Smith and Scherer, 2018</xref>). Dozens of large-scale genetic studies have since been conducted on ASD patients and their families, leading to hundreds of risk genes being identified. While these proteins have diverse functions, a majority of reproducible hits come from two broad classes of proteins: those involved in synapse formation, and those involved in transcriptional regulation and chromatin-remodeling pathways (<xref ref-type="bibr" rid="B35">De Rubeis et al., 2014</xref>).</p>
<p>Synapse-related risk genes include those encoding cell-adhesion proteins such as neuroligins, neurexins, and cadherins; synaptic vesicle cycling proteins synapsin-1 (SYN1) and synapsin-2 (SYN2); ion transport proteins such as sodium voltage-gated channel alpha subunit 2 (SCN2A), calcium voltage-gated channel subunit alpha1 E (CACNA1E), calcium voltage-gated channel auxiliary subunit beta 2 (CACNB2), potassium voltage-gated channel subfamily Q members 3 and 5 (KCNQ3 and KCNQ5), potassium voltage-gated channel subfamily D member 2 (KCND2), glutamate receptor signaling protein SH3 and multiple ankyrin repeat domains 3 (SHANK3), synaptic Ras GTPase activating protein 1 (SYNGAP1), and gamma-aminobutyric acid type A receptor gamma3 subunit (GABRG3) (<xref ref-type="bibr" rid="B81">Jamain et al., 2003</xref>; <xref ref-type="bibr" rid="B42">Durand et al., 2012</xref>; <xref ref-type="bibr" rid="B167">Schmunk and Gargus, 2013</xref>; <xref ref-type="bibr" rid="B55">Giovedí et al., 2014</xref>; <xref ref-type="bibr" rid="B182">Stessman et al., 2017</xref>). <italic>In vivo</italic> data supports the implication of synapse pathology and abnormal neural network formation in ASD.</p>
<p>Additional susceptibility loci impact transcription of other proteins through various mechanisms. For example, multiple studies have found an increased <italic>de novo</italic> mutation load in regulatory elements of ASD risk genes in patients (<xref ref-type="bibr" rid="B196">Turner et al., 2016</xref>, <xref ref-type="bibr" rid="B195">2017</xref>; <xref ref-type="bibr" rid="B175">Short et al., 2018</xref>). The broad class of susceptibility genes that impacts transcription and chromatin-remodeling pathways includes <italic>MeCP2, UBE3A</italic>, chromodomain helicase DNA binding protein 8 (<italic>CHD8</italic>), activity dependent neuroprotector homeobox (<italic>ADNP</italic>), pogo transposable element derived with ZNF domain (<italic>POGZ)</italic>, fragile X mental retardation protein (<italic>FMRP</italic>), and RNA binding forkhead box (<italic>RBFOX</italic>) genes (<xref ref-type="bibr" rid="B22">Carney et al., 2003</xref>, p. 2; <xref ref-type="bibr" rid="B163">Samaco et al., 2005</xref>; <xref ref-type="bibr" rid="B35">De Rubeis et al., 2014</xref>; <xref ref-type="bibr" rid="B182">Stessman et al., 2017</xref>; <xref ref-type="bibr" rid="B194">Tran et al., 2019</xref>). These pathogenic variants have the potential to induce extremely widespread effects. For example, <xref ref-type="bibr" rid="B194">Tran et al. (2019)</xref> recently showed that <italic>FMRP</italic> and fragile X related protein 1 (<italic>FXRP1</italic>) mutations can result in abnormal RNA-editing enzyme activity, resulting in a global bias for adenosine-to-inosine hypoediting in ASD brains. Diverse phenotypes that may result are further discussed in the epigenetics section.</p>
<sec id="S2.SS1.SSS1">
<title>Somatic Mosaicism and ASD Risk</title>
<p>Disease-causing variations were conventionally thought to be familial/inherited and present in every cell in the body. However, the role of somatic mosaicism, which is the result of a post-zygotic DNA mutation, is increasingly being recognized as crucial to various neurodevelopmental diseases including autism (<xref ref-type="bibr" rid="B144">Poduri et al., 2013</xref>; <xref ref-type="bibr" rid="B160">Ronemus et al., 2014</xref>; <xref ref-type="bibr" rid="B37">D’Gama and Walsh, 2018</xref>). During neurogenesis, each progenitor gives rise to roughly five single nucleotide variants (SNV) per day as the brain rapidly develops (<xref ref-type="bibr" rid="B7">Bae et al., 2018</xref>; <xref ref-type="bibr" rid="B37">D’Gama and Walsh, 2018</xref>). Studies estimate that of <italic>de novo</italic> pathogenic variations, roughly 5–7% are postzygotic, though estimates of up to 22% have been reported (<xref ref-type="bibr" rid="B1">Acuna-Hidalgo et al., 2015</xref>; <xref ref-type="bibr" rid="B49">Freed and Pevsner, 2016</xref>; <xref ref-type="bibr" rid="B100">Krupp et al., 2017</xref>; <xref ref-type="bibr" rid="B111">Lim et al., 2017</xref>). Most mutations are harmless, but variations in exons can be extremely detrimental. Pathogenic somatic variations have been connected to ASD, Rett syndrome, tuberous sclerosis, intellectual disability, schizophrenia, and many other disorders (<xref ref-type="bibr" rid="B28">Clayton-Smith et al., 2000</xref>; <xref ref-type="bibr" rid="B18">Bourdon et al., 2001</xref>; <xref ref-type="bibr" rid="B149">Qin et al., 2010</xref>; <xref ref-type="bibr" rid="B53">Gilissen et al., 2014</xref>; <xref ref-type="bibr" rid="B1">Acuna-Hidalgo et al., 2015</xref>; <xref ref-type="bibr" rid="B197">Tyburczy et al., 2015</xref>; <xref ref-type="bibr" rid="B49">Freed and Pevsner, 2016</xref>; <xref ref-type="bibr" rid="B38">Dou et al., 2017</xref>; <xref ref-type="bibr" rid="B39">Doyle et al., 2017</xref>; <xref ref-type="bibr" rid="B100">Krupp et al., 2017</xref>; <xref ref-type="bibr" rid="B37">D’Gama and Walsh, 2018</xref>).</p>
<p>Until recently, our understanding of somatic mosaicism in ASD was restricted primarily to case reports (<xref ref-type="bibr" rid="B136">Oliveira et al., 2003</xref>; <xref ref-type="bibr" rid="B166">Sauter et al., 2003</xref>; <xref ref-type="bibr" rid="B138">Papanikolaou et al., 2006</xref>; <xref ref-type="bibr" rid="B68">Havlovicova et al., 2007</xref>; <xref ref-type="bibr" rid="B213">Yurov et al., 2007</xref>; <xref ref-type="bibr" rid="B24">Castermans et al., 2008</xref>; <xref ref-type="bibr" rid="B85">Kakinuma et al., 2008</xref>; <xref ref-type="bibr" rid="B199">Vorstman et al., 2011</xref>). Several recent investigations of whole exome-sequencing (WES) data from large cohorts have been instrumental in shaping our understanding of the role of somatic mosaicism, which is currently estimated to account for roughly 3–5% of simplex ASD cases (<xref ref-type="bibr" rid="B49">Freed and Pevsner, 2016</xref>; <xref ref-type="bibr" rid="B100">Krupp et al., 2017</xref>). <xref ref-type="bibr" rid="B111">Lim et al. (2017)</xref> used WES analysis of 5,947 ASD-affected families and determined that somatic variations in autistic individuals were more likely to be in critical exons than variations in control siblings. Interestingly, they found that the pathogenic variants had enhanced expression in the amygdala, an area critical for emotional response and social awareness (<xref ref-type="bibr" rid="B152">Rasia-Filho et al., 2000</xref>). In another large WES study, new risk genes identified were enriched in the cerebellum, which suggests potential coordination difficulty that could be related to gait disorders common in autistic children (<xref ref-type="bibr" rid="B38">Dou et al., 2017</xref>). <xref ref-type="bibr" rid="B49">Freed and Pevsner (2016)</xref> analyzed 2,388 families and identified an ascertainment bias for pathogenic mosaic variations in ASD individuals relative to unaffected siblings. These large-scale sequencing studies of post-zygotic mutations have both confirmed previously implicated candidate genes, such as <italic>SCN2A</italic>, in addition to revealing dozens of new risk genes and establishing somatic mosaicism as a significant factor in ASD etiology (<xref ref-type="bibr" rid="B111">Lim et al., 2017</xref>).</p>
</sec>
<sec id="S2.SS1.SSS2">
<title>CNVs Contribute to ASD Susceptibility</title>
<p>Copy number variations (CNVs) are submicroscopic structural variants in chromosomes that include duplications, deletions, translocations, and inversions, sometimes stretching several kilobases (<xref ref-type="bibr" rid="B119">Marshall et al., 2008</xref>). CNV can either be inherited or arise <italic>de novo</italic> (<xref ref-type="bibr" rid="B191">Thapar and Cooper, 2013</xref>). Many genes may be affected with these changes, but not all are necessarily drivers of disease. Studies have found a higher load of rare, genic CNVs in autistic individuals, implicating these variants in ASD pathology (<xref ref-type="bibr" rid="B171">Sebat et al., 2007</xref>; <xref ref-type="bibr" rid="B142">Pinto et al., 2010</xref>; <xref ref-type="bibr" rid="B143">Pizzo et al., 2019</xref>). CNV is now understood as an extremely important contributing factor in ASD susceptibility, and current estimates postulate that these variations directly cause roughly 10% of ASD cases (<xref ref-type="bibr" rid="B52">Geschwind, 2011</xref>).</p>
<p>Studies of how individual CNVs contribute to ASD have been done for more frequent structural variants, such as 16p11.2 duplications. The majority of the 25 genes in this region are highly active during nervous system development and are critical for proper formation (<xref ref-type="bibr" rid="B14">Blaker-Lee et al., 2012</xref>). While the alteration of many genes involved in development suggests a mechanism for the diverse symptoms observed in ASD, <xref ref-type="bibr" rid="B62">Golzio et al. (2012)</xref> reported that only one gene in the 16p11.2 region, potassium channel tetramerization domain containing 13 (<italic>KCTD13</italic>), seems to be the major driver for neuropsychiatric disease. Duplications or deletions of this gene are thought to affect synaptic transmission through altered regulation of Ras homolog family member A (<italic>RHOA</italic>) (<xref ref-type="bibr" rid="B44">Escamilla et al., 2017</xref>). However, <xref ref-type="bibr" rid="B44">Escamilla et al. (2017)</xref> also hypothesized that <italic>KCTD13</italic> deletions alone are not likely to be sufficient for disease. Mouse models suggest another gene in the 16p11.2 region as a driver of disease – mitogen-activated protein kinase 3 (<italic>MAP3</italic>) – with deletions resulting in altered cortical cytoarchitecture and reduced brain size (<xref ref-type="bibr" rid="B146">Pucilowska et al., 2015</xref>). Likely, the real driver of disease in 16p11.2 duplications or deletions is not from just one gene, but an interaction of all 25 contributing to susceptibility. <xref ref-type="bibr" rid="B78">Iyer et al. (2018)</xref> systematically investigated interaction between genes in the 16p11.2 region, using RNAi in <italic>Drosophila</italic> to test 565 pairwise knockdowns. In addition to 24 modifying interactions discovered between pairs of genes within the 16p11.2 region, they also found 46 interactions between 16p11.2 genes and others involved in neurodevelopment (<xref ref-type="bibr" rid="B78">Iyer et al., 2018</xref>). This strongly suggests that modifying interactions within CNVs result in the complex phenotypes observed and may not be elucidated from studies with single genes, a phenomenon that is likely true for other CNV regions in addition to 16p11.2.</p>
<p>The disease mechanisms of other CNVs are less frequently studied due to the paucity of commonly affected regions. Even the most prevalent ASD-associated CNVs, such as 15q11-13 as well as 16p11.2, are only present in roughly 1% of autism cases (<xref ref-type="bibr" rid="B102">Kumar et al., 2008</xref>; <xref ref-type="bibr" rid="B119">Marshall et al., 2008</xref>; <xref ref-type="bibr" rid="B202">Weiss et al., 2008</xref>; <xref ref-type="bibr" rid="B120">Marshall and Scherer, 2012</xref>). In addition, there are no known CNVs with complete penetrance; studies that find CNVs with significant correlation to ASD often detect non-ASD carriers, or ASD siblings without the variant (<xref ref-type="bibr" rid="B119">Marshall et al., 2008</xref>). One useful approach in the midst of this heterogeneity is to assess common functional networks affected. Repeatedly, studies have shown that autistic individuals have deletions in synaptic genes, such as <italic>SHANK3</italic>, dipeptidyl peptidase-like 10 (<italic>DPP10</italic>), neuroligins, and neurexins (<xref ref-type="bibr" rid="B192">The Autism Genome Project Consortium et al., 2007</xref>; <xref ref-type="bibr" rid="B119">Marshall et al., 2008</xref>; <xref ref-type="bibr" rid="B60">Glessner et al., 2009</xref>; <xref ref-type="bibr" rid="B142">Pinto et al., 2010</xref>, <xref ref-type="bibr" rid="B141">2014</xref>; <xref ref-type="bibr" rid="B120">Marshall and Scherer, 2012</xref>). Other common functional gene sets with rare CNVs include those involved in cell proliferation and development, chromatin regulation, and ubiquitin pathways (<xref ref-type="bibr" rid="B60">Glessner et al., 2009</xref>; <xref ref-type="bibr" rid="B142">Pinto et al., 2010</xref>, <xref ref-type="bibr" rid="B141">2014</xref>).</p>
<p>With certain CNVs, copy number dosage appears to affect disease phenotype. For example, <xref ref-type="bibr" rid="B70">Horev et al. (2011)</xref> observed a dose-dependent effect and change in brain structure in mice with 16p11.2 deletions and duplications, but this effect is not as established in humans (<xref ref-type="bibr" rid="B102">Kumar et al., 2008</xref>). Another study investigating CNV in the locus containing the <italic>UBE3A</italic> gene also report a positive correlation between duplication and autistic traits in mice, as well as decreased glutamatergic synaptic transmission (<xref ref-type="bibr" rid="B176">Smith et al., 2011</xref>). In humans, <xref ref-type="bibr" rid="B179">Stefansson et al. (2014)</xref> analyzed a 15q11.2 CNV region of autistic individuals and found two brain areas with dose-dependent structural and functional effects. Interestingly, some non-ASD/schizophrenic controls who were diagnosed with dyslexia and dystaxia also exhibited the same structural changes (<xref ref-type="bibr" rid="B179">Stefansson et al., 2014</xref>). In another study with humans, <xref ref-type="bibr" rid="B56">Girirajan et al. (2013)</xref> reported a dose-dependent effect from their microarray analysis with identified CNVs in ASD-associated genes, finding a positive correlation between duplication size increase and autism severity increase, but no correlation between duplication size and non-verbal IQ. CNV are often critical and complex contributors to ASD risk, but patients with similar structural variants may have highly variable phenotypes. Following sections will discuss how non-causative modifiers play an important role in modulating CNV pathogenicity.</p>
</sec>
<sec id="S2.SS1.SSS3">
<title>Epigenetic Regulation and ASD</title>
<p>Genes with epigenetic-modulating functions are highly involved in ASD susceptibility. A recent review of 215 candidate genes estimated that 19.5% are epigenetic regulators, suggesting the potential for diverse disease phenotypes from few pathogenic variants (<xref ref-type="bibr" rid="B40">Duffney et al., 2018</xref>). Another study suggested that risk genes with high penetrance were typically located in the nucleus and involved in modulation of expression, or tied to the protein-protein interaction network essential in guiding CNS developmental patterning (<xref ref-type="bibr" rid="B23">Casanova et al., 2016</xref>). Twin studies particularly demonstrate the profound ways epigenetics can modulate disease phenotype; for example, a study of 50 pairs of monozygotic twins discordant for ASD reported numerous autism-associated differentially methylated regions, with methylation patterns at some CpG sites common to symptom groups (<xref ref-type="bibr" rid="B208">Wong et al., 2014</xref>).</p>
<p>Though the scientific and medical community still has a great deal to learn about epigenetic modulation of ASD, patterns have emerged from large-scale epigenomic studies. Susceptibility loci often include genes involved in methylation such as <italic>KMT2C</italic>, lysine methyltransferase 5B (<italic>KMT5B</italic>), and lysine demethylase 6B (<italic>KDM6B</italic>); chromatin remodeling proteins including MeCP2, CHD8, and POGZ; RNA-binding/splicing proteins such as FMRP and the RBFOX family, post-translational modification proteins like UBE3A, mindbomb E3 ubiquitin protein ligase 1 (MIB1); or transcription factors like ADNP and additional sex combs like 3 (ASXL3) (<xref ref-type="bibr" rid="B35">De Rubeis et al., 2014</xref>). Targets of these proteins can range from few to hundreds, and often include pathways previously implicated in autism, such as synaptic formation. To demonstrate how mutations in a single epigenetic regulator can modify many other risk genes, we will look more in depth at two key susceptibility genes: <italic>MeCP2</italic> and <italic>UBE3A</italic>.</p>
<p>MeCP2 is a chromatin modifier that is consistently implicated in ASD. In a healthy individual, the binding action of MeCP2 has been shown to regulate many genes with synaptic function, such as <italic>GABRB3</italic>, brain derived neurotrophic factor (<italic>BDNF</italic>), distal-less homeobox 5 (<italic>DLX5</italic>), insulin like growth factor binding protein 3 (<italic>IGFBP3</italic>), cyclin dependent kinase like 1 (<italic>CDKL1</italic>), protocadherin beta 1 (<italic>PCDHB1</italic>), protocadherin 7 (<italic>PCDH7</italic>), and lin-7 homolog A (LIN7A) (<xref ref-type="bibr" rid="B163">Samaco et al., 2005</xref>; <xref ref-type="bibr" rid="B101">Kubota and Mochizuki, 2016</xref>). It also serves post-translational functions (<xref ref-type="bibr" rid="B27">Cheng and Qiu, 2014</xref>). In addition, MeCP2 is the rate-limiting factor in regulating glutamatergic synapse formation during development, which implicates its involvement in yet another important aspect of ASD pathology (<xref ref-type="bibr" rid="B25">Chao et al., 2007</xref>). MeCP2 is shown to be reduced in the frontal cortex of ASD individuals due to increased methylation of its promoter (<xref ref-type="bibr" rid="B163">Samaco et al., 2005</xref>; <xref ref-type="bibr" rid="B130">Nagarajan et al., 2006</xref>, <xref ref-type="bibr" rid="B131">2008</xref>).</p>
<p>UBE3A, an E3 ubiquitin protein ligase, is a second important epigenetic regulator strongly implicated in ASD pathology. It is modulated by MeCP2, but can be causative on its own (<xref ref-type="bibr" rid="B163">Samaco et al., 2005</xref>, p. 2). <italic>UBE3A</italic> lies in the chromosomal region 15q11-13, which is commonly duplicated in autism. Dose-dependent effects have been positively correlated with reduced excitatory synaptic transmission, delay of first word, and psychomotor regression (<xref ref-type="bibr" rid="B63">Guffanti et al., 2011</xref>; <xref ref-type="bibr" rid="B176">Smith et al., 2011</xref>; <xref ref-type="bibr" rid="B210">Xu et al., 2018</xref>). The mechanism of UBE3A’s pathological activity can be hypothesized based on its function as a ubiquitin ligase, which targets proteins for degradation, but research is still revealing exactly how these dose-dependent impairments occur. <xref ref-type="bibr" rid="B108">Lee et al. (2014)</xref> identified four proteosome-related proteins that were direct substrates of UBE3A. Overexpression of <italic>UBE3A</italic> and one of its substrates, proteasome 26S subunit, non-ATPase 4 (<italic>Rpn10</italic>), led to increased accumulation of ubiquitinated proteins, suggesting a proteostatic imbalance. Proteosome health has been strongly implicated in dendritic spine outgrowth, linking UBE3A with one of the key pathologies observed in autism (<xref ref-type="bibr" rid="B65">Hamilton et al., 2012</xref>; <xref ref-type="bibr" rid="B147">Puram et al., 2013</xref>). Its involvement in Wnt signaling could also cause significant perturbation during development (<xref ref-type="bibr" rid="B212">Yi et al., 2017</xref>). <italic>MeCP2</italic> and <italic>UBE3A</italic> are just two examples of how one altered gene can have extremely far-reaching effects.</p>
<p>Large-scale epigenetic studies have also helped achieve a broader picture of epigenetic mis-regulation in ASD. <xref ref-type="bibr" rid="B186">Sun et al. (2016)</xref> conducted a histone acetylome-wide association study on 257 post-mortem prefrontal and temporal cortex samples. Surprisingly, they found that &gt;68% of both syndromic and idiopathic cases shared a common acetylome signature at roughly 5,000 enhancer regions (<xref ref-type="bibr" rid="B186">Sun et al., 2016</xref>). Intriguingly, a SHANK3 mouse model of autism displayed rescued behavioral phenotypes when treated with a potent histone deacetylase inhibitor, reinforcing the role of epigenetics in ASD (<xref ref-type="bibr" rid="B148">Qin et al., 2018</xref>). Ladd-Acosta and coworkers measured over 485,000 CpG loci in post-mortem brain tissue from 40 individuals and identified four differentially methylated regions. Three sites were found in cortical tissue: the proline rich transmembrane protein 1 (<italic>PRRT1</italic>) 3’ UTR, promoter regions of tetraspanin 32 (<italic>TSPAN32</italic>), and <italic>C11orf21.</italic> The last site, an alternative promoter for succinate dehydrogenase complex flavoprotein subunit A pseudogene 3 (<italic>SDHAP3</italic>), was found in cerebellar tissue (<xref ref-type="bibr" rid="B104">Ladd-Acosta et al., 2014</xref>). Affected pathways implied in these studies and others include synaptic transmission, immune function, ion transport, and GABAergic genes (<xref ref-type="bibr" rid="B132">Nardone and Elliott, 2016</xref>; <xref ref-type="bibr" rid="B186">Sun et al., 2016</xref>; <xref ref-type="bibr" rid="B4">Andrews et al., 2017</xref>; <xref ref-type="bibr" rid="B216">Zhubi et al., 2017</xref>).</p>
<p><xref ref-type="bibr" rid="B127">Mor et al. (2015)</xref> took a different approach, using small RNA sequencing data and correlating results to genome-wide DNA methylation data to find dysregulated miRNAs. miRNAs that were found to be significantly expressed in the ASD brain were linked to synaptic function, consistent with data from numerous other studies. They also discovered a link to the oxytocin receptor (<italic>OXTR</italic>) gene, suggesting attenuated <italic>OXTR</italic> expression in the autistic brain. This finding was supported by a study that found fetal membranes from preterm birth had hypermethylated <italic>OXTR</italic>, potentially linking an environmental risk factor to a pathological mechanism (<xref ref-type="bibr" rid="B13">Behnia et al., 2015</xref>). Another risk gene with epigenetic functions is engrailed homeobox 2 (<italic>EN2</italic>), a homeobox gene with an unusual methylation pattern in ASD that has been hypothesized to cause abnormal cerebellar Purkinje growth (<xref ref-type="bibr" rid="B82">James et al., 2013</xref>). The list of ASD risk genes with epigenetic functions is vast, suggesting a mechanism by which few mutations can result in widespread misregulation of gene expression. Because of this, genes with epigenetic functions and their substrates may be promising targets of therapies. For example, mutations in <italic>FMRP</italic>, a chromatin remodeler, result in widespread gene expression abnormalities, but a recent study found that inhibition of FMRP target bromodomain containing 4 (<italic>BRD4</italic>) alleviated many of the disease characteristics (<xref ref-type="bibr" rid="B97">Korb et al., 2017</xref>). Proteins with epigenetic-regulating function may also be key targets of disease modifiers, a concept that will be discussed later in this review.</p>
</sec>
</sec>
<sec id="S2.SS2">
<title>ASD Risk Genes Overlap With Other Diseases</title>
<p>Large-scale sequencing studies of major psychiatric diseases have revealed extensive overlap in risk loci, challenging the classification of these conditions as distinctive disorders. In 2013, the Cross-Disorder Group of the Psychiatric Genomics Consortium (PGC) conducted a massive study with 33,332 cases and 27,888 controls in order to identify pathogenic variants shared between ASD, schizophrenia, bipolar disorder, ADHD, and major depressive disorder (<xref ref-type="bibr" rid="B33">Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013</xref>; <xref ref-type="bibr" rid="B34">Cross-Disorder Group of the Psychiatric Genomics Consortium et al., 2013</xref>). In addition to establishing varying degrees of pair-wise crossover, they found loci that reached genome-wide significance for all five disorders near the following genes: inter-alpha-trypsin inhibitor heavy chain 3 (<italic>ITIH3</italic>), arsenite methyltransferase (<italic>AS3MT</italic>), calcium voltage-gated channel subunit alpha1 C (<italic>CACNA1C</italic>), and <italic>CACNB2</italic>. <xref ref-type="bibr" rid="B59">Glessner et al. (2017)</xref> have also conducted a large-scale meta-analysis of structural variants across the same diseases and correlated structural variants in the loci of dedicator of cytokinesis 8 (<italic>DOCK8</italic>) and KN motif and ankyrin repeat domains 1 (<italic>KANK1</italic>) with all five conditions. <xref ref-type="bibr" rid="B168">Schork et al. (2019)</xref> recently hypothesized that abnormal gene regulation in radial glia and interneurons during mid-gestation is a mechanism of shared risk, after using GWAS to identify susceptibility loci in genes including phosphodiesterase 1A (<italic>PDE1A</italic>), protein phosphatase 1 regulatory inhibitor subunit 1C (<italic>PPP1R1C</italic>), <italic>RHOA</italic>, immunoglobulin superfamily member 11 (<italic>IGSF11</italic>), and sortilin related VPS10 domain containing receptor 3 (SORC3).</p>
<p>Studies also report shared susceptibility genes across a more restricted set of psychiatric diseases. For example, ASD, intellectual disability (ID), and schizophrenia have been found to share risk loci in FMRP targets, <italic>CHD5</italic>, <italic>CHD8</italic>, <italic>SCN2A</italic>, and neurexin 1 (NRXN1) (<xref ref-type="bibr" rid="B76">Iossifov et al., 2014</xref>; <xref ref-type="bibr" rid="B201">Wang et al., 2019</xref>). <xref ref-type="bibr" rid="B201">Wang et al. (2019)</xref> also found commonalities across ASD, ID, and bipolar disorder with increased incidence of <italic>de novo</italic> pathogenic variants in periodic circadian regulator 1 (<italic>PER1</italic>) and lysine methyltransferase 2C (<italic>KMT2C</italic>). <xref ref-type="bibr" rid="B90">Khanzada et al. (2017)</xref> found 23 susceptibility genes common to ASD, bipolar disorder, and schizophrenia including dopamine receptor D2 (<italic>DRD2</italic>), cholinergic receptor nicotinic alpha 7 subunit (<italic>CHRNA7</italic>), 5-hydroxytryptamine receptor 2A (<italic>HTR2A</italic>), solute carrier family 6 member 3 (<italic>SLC6A3</italic>), and tryptophan hydroxylase 2 (<italic>TPH2</italic>). Hit genes were primarily involved in dopamine and serotonin homeostasis, suggesting a potential mechanism for abnormal emotional regulation observed across all three disorders (<xref ref-type="bibr" rid="B90">Khanzada et al., 2017</xref>). The immense crossover revealed in these studies intriguingly suggests some level of shared etiology across psychiatric conditions, despite having clinically distinct presentations.</p>
<p>Of the four other diseases assessed in the PGC study, the most highly correlated disease to ASD was schizophrenia (<xref ref-type="bibr" rid="B34">Cross-Disorder Group of the Psychiatric Genomics Consortium et al., 2013</xref>). Previous epidemiological studies had suggested their linkage, reporting increased risk of ASD in children with schizophrenic parents and significant co-morbidity of child-onset schizophrenia and autism (<xref ref-type="bibr" rid="B150">Rapoport et al., 2009</xref>; <xref ref-type="bibr" rid="B185">Sullivan et al., 2012</xref>). A follow-up report to the 2013 PGC study estimated genetic correlation between the two diseases to be 23%, with shared risk loci including several genes involved in neurodevelopment, such as forkhead box P1 (<italic>FOXP1</italic>), exostosin glycosyltransferase 1 (<italic>EXT1</italic>), astrotactin 2 (<italic>ASTN2</italic>), mono-ADP ribosylase 2 (<italic>MACROD2</italic>), and histone deacetylase 4 (<italic>HDAC4</italic>) (<xref ref-type="bibr" rid="B193">The Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium, 2017</xref>). In addition to susceptibility genes involved in neurodevelopment, other studies have also reported shared susceptibility in genes affecting chromatin remodeling, oxidative stress response, and lipid metabolism (<xref ref-type="bibr" rid="B124">McCarthy et al., 2014</xref>; <xref ref-type="bibr" rid="B111">Lim et al., 2017</xref>).</p>
<p>Many studies have also found a significant correlation between autistic and ADHD scored traits. This includes a study of autistic symptoms in ADHD probands and siblings, autistic trait correlation in an ADHD twin sample, and an association between autistic and ADHD traits in the general population (<xref ref-type="bibr" rid="B153">Reiersen et al., 2007</xref>; <xref ref-type="bibr" rid="B159">Ronald et al., 2008</xref>; <xref ref-type="bibr" rid="B128">Mulligan et al., 2009</xref>; <xref ref-type="bibr" rid="B180">Stergiakouli et al., 2017</xref>). <xref ref-type="bibr" rid="B134">Nijmeijer et al. (2010)</xref> identified five specific genetic loci that were associated with ASD traits in children with ADHD: 7q36, 16p13, 18p11, 15q24, and 12q24. A study investigating the overlap of pathological structural variants in ADHD and ASD found significant overlap in genes related to a wide variety of processes, including the nicotinic receptor signaling pathway and cell division (<xref ref-type="bibr" rid="B121">Martin et al., 2014</xref>). The shared heritability of ASD and ADHD is still being explored, and is further discussed in a review by <xref ref-type="bibr" rid="B158">Rommelse et al. (2010)</xref>.</p>
<p>Since ASD is a multigenic and highly heterogeneous disease that often co-occurs with other conditions, it can be difficult to distinguish which genes truly have overlapping risk for multiple psychiatric conditions, and which variations are responsible for the common disease phenotypes. For example, the ubiquitin ligase gene <italic>UBE3A</italic> is implicated in both autism and Angelman Syndrome, a condition distinct from ASD but with similar symptoms, such as movement and speech defects. Interestingly, Angelman Syndrome is generally associated with <italic>UBE3A</italic> deletions, while ASD can be caused by duplications – yet the same individual can be diagnosed with both syndromes (<xref ref-type="bibr" rid="B140">Peters et al., 2004</xref>; <xref ref-type="bibr" rid="B207">Williams et al., 2010</xref>; <xref ref-type="bibr" rid="B176">Smith et al., 2011</xref>; <xref ref-type="bibr" rid="B86">Kalsner and Chamberlain, 2015</xref>; <xref ref-type="bibr" rid="B211">Yi et al., 2015</xref>). Another example is intellectual disability, which co-occurs with autism in roughly 45% of cases (<xref ref-type="bibr" rid="B105">Lai et al., 2014</xref>). Multiple studies have found that ASD and intellectual disability share risk loci (<xref ref-type="bibr" rid="B142">Pinto et al., 2010</xref>; <xref ref-type="bibr" rid="B124">McCarthy et al., 2014</xref>), but overlapping phenotypes are a potentially confounding factor. Similarly, other risk genes for ASD are epigenetic regulators whose effectors are associated with different diseases (<xref ref-type="bibr" rid="B163">Samaco et al., 2005</xref>; <xref ref-type="bibr" rid="B142">Pinto et al., 2010</xref>; <xref ref-type="bibr" rid="B125">Michaelson et al., 2017</xref>). The interaction and overlap between psychiatric disorders is complex, and much is left to discern regarding shared disease mechanisms.</p>
</sec>
</sec>
<sec id="S3">
<title>Modifiers in ASD</title>
<sec id="S3.SS1">
<title>Genetic Modifiers</title>
<p>Though significant progress has been made in determining genetic causes of ASD, many aspects of how pathogenic variants regulate genetic susceptibility remain unknown. Individuals with the same variants can have widely heterogeneous disease presentations and levels of disability. Presence of second modulating variants that may interact with other susceptibility loci are one possible explanation of this heterogeneity. This “second hit” could be somatic – a phenomenon first proposed to cause disease by Alfred Knudson in the context of retinoblastomas – or in the germline, a “two-locus model” previously explored in conditions such as Hirschprung disease (<xref ref-type="bibr" rid="B93">Knudson, 1971</xref>; <xref ref-type="bibr" rid="B47">Fisher and Scambler, 1994</xref>; <xref ref-type="bibr" rid="B122">McCallion et al., 2003</xref>). To date, genetic evidence supporting a multiplex theory of autism has primarily been found for germline second-hits. Studies with CNVs will be discussed first, followed by a brief overview of known modulating SNPs. These investigations of how non-causative variants may modify the ASD phenotype are challenging to undertake, as few autistic individuals have the same pathogenic variants. In addition, there is not yet a complete understanding of which CNVs and SNPs are pathogenic in ASD.</p>
<p>One way to circumvent these issues is to investigate an autism subtype with a monogenic cause, such as Rett Syndrome. <xref ref-type="bibr" rid="B5">Artuso et al. (2011)</xref> used this strategy and identified 15 “likely” and 14 “unlikely” modulators of the RTT phenotype based on array comparative genome hybridization with eight RTT subjects. Another valuable approach is to assess monozygotic twins with a discordant phenotype. Several studies have assessed potential differences in CNVs or epigenetic regulation in discordant monozygotic twins, revealing potential methylation pattern differences in one case and anomalies in the 2p25.3 region in another (<xref ref-type="bibr" rid="B20">Bruder et al., 2008</xref>; <xref ref-type="bibr" rid="B103">Kunio et al., 2013</xref>; <xref ref-type="bibr" rid="B155">Rio et al., 2013</xref>). However, a study involving 100 twin pairs failed to find differences in CNVs that could explain the discordant phenotypes (<xref ref-type="bibr" rid="B178">Stamouli et al., 2018</xref>). The authors still acknowledge postzygotic mosaicism as a potential modifier and encourage more studies to help develop a clearer understanding of CNV modulating activity.</p>
<p>A handful of reports also exist of putative modifying CNVs in polygenic ASD cases with unrelated subjects. For example, <xref ref-type="bibr" rid="B57">Girirajan et al. (2012)</xref> found that children with two CNVs not known to be pathological were eight times more likely to be diagnosed with developmental delay than controls. In the same year, a study of <italic>SHANK2</italic> pathogenic variants found abnormalities in both individuals with neuropsychiatric disease and controls, suggesting the presence of additional variants in order to cause disease. Three of the patients with <italic>de novo SHANK2</italic> mutations were also found to have deletions of <italic>CHRNA7</italic> and cytoplasmic FMR1 interacting protein 1 (<italic>CYFIP1</italic>) – both previously implicated in ASD – supporting a “multiple-hit” model of autism (<xref ref-type="bibr" rid="B107">Leblond et al., 2012</xref>). <italic>CHRNA7</italic> was also suggested as a potential modifier in an earlier study by <xref ref-type="bibr" rid="B187">Szafranski et al. (2010)</xref>. <xref ref-type="bibr" rid="B9">Barber et al. (2013)</xref> provided further support for a multiple-loci model of ASD upon finding that patients with 16p12.1 duplications had a more severe phenotype when a second large CNV was present. Included in these hypothesized modifier regions were genes G protein regulated inducer of neurite outgrowth 2 (<italic>GPRIN2</italic>) – previously implicated as a modifier in the study by <xref ref-type="bibr" rid="B5">Artuso et al. (2011)</xref> – and steroid sulfatase (<italic>STS</italic>), which was formerly thought to be non-causative (<xref ref-type="bibr" rid="B110">Li et al., 2010</xref>). More recently, an analysis of 20,226 patient records revealed 19 patients with CNVs in contactin 6 (<italic>CNTN6</italic>), a gene hypothesized to be involved in neurodevelopmental disorders including ASD (<xref ref-type="bibr" rid="B154">Repnikova et al., 2019</xref>). The authors were not able to find any significant genotype-phenotype relationships and concluded that CNV in <italic>CNTN6</italic> were likely benign or modifying, but not causative of disease.</p>
<p>In addition to CNVs, there may be thousands of smaller pathogenic variants – such as SNPs and indels – that also modulate severity. For example, in a study of developmental delay, individuals that only carried a specific 16p12.1 microdeletion had a less severe phenotype than individuals with random second variants (<xref ref-type="bibr" rid="B58">Girirajan et al., 2010</xref>). One study of individuals with 22q11.2 deletion syndrome – all haploinsufficient for an mGluR network gene – found that 20% who were co-diagnosed with autism had second-hit pathogenic variants, while only 2% of 22q11DS individuals without autism had second hits (<xref ref-type="bibr" rid="B203">Wenger et al., 2016</xref>). <xref ref-type="bibr" rid="B17">Bonnet-Brilhault et al. (2016)</xref> assessed a family affected with ID and ASD due to <italic>NLGN4X</italic> pathogenic variants and found that individuals with ASD – but not ID or controls – had second-hit variants in glycine receptor beta (<italic>GRLB</italic>) and ankyrin 3 (<italic>ANK3</italic>). Additional evidence may exist, but GWAS and WES studies have tended to focus on causative susceptibility loci. Therefore, other variants which are not causative by themselves are not often emphasized or even reported. The emerging study of all types of genetic modifiers is a relatively recent development, and continuing advancements in sequencing technology, analyzing software, and expansion of databases should lay the framework for significant advancements in the near future.</p>
</sec>
<sec id="S3.SS2">
<title>Epigenetics and the Environment</title>
<p>Autism susceptibility is currently estimated to be 40–80% genetic. Environmental factors – likely acting through epigenetic regulation as the major mechanism – presumably compromise the remainder of the risk. Hundreds of potential environmental factors have been suggested to contribute to risk, such as increased parental age (especially paternal), maternal complications or infections during pregnancy, or prenatal exposure to anticonvulsants (<xref ref-type="bibr" rid="B151">Rasalam et al., 2005</xref>; <xref ref-type="bibr" rid="B96">Kong et al., 2012</xref>; <xref ref-type="bibr" rid="B137">O’Roak et al., 2012</xref>; <xref ref-type="bibr" rid="B135">Ohkawara et al., 2015</xref>). In-depth reviews of these findings can be found elsewhere (<xref ref-type="bibr" rid="B51">Gardener et al., 2009</xref>; <xref ref-type="bibr" rid="B26">Chaste and Leboyer, 2012</xref>; <xref ref-type="bibr" rid="B115">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="B88">Karimi et al., 2017</xref>; <xref ref-type="bibr" rid="B126">Modabbernia et al., 2017</xref>; <xref ref-type="bibr" rid="B15">Bölte et al., 2019</xref>). In this review, we will only discuss the epigenetic modifying effects of valproic acid – an anticonvulsant – as one example of the widespread modifications that an environmental factor can induce. Valproic acid has been hypothesized to modify gene expression through histone deacetylase inhibition activity and is sometimes used to induce an autistic phenotype in animal models (<xref ref-type="bibr" rid="B89">Kataoka et al., 2013</xref>). Examples of its far-reaching effects include apoptotic cell death in the neocortex, decreased proliferation in the ganglionic eminence, increased homeobox A1 (<italic>HOXA1</italic>) expression, abnormal serotonergic differentiation via Achaete-Scute family BHLH transcription factor 1 (<italic>ASCL1</italic>) silencing, disrupted serotonin homeostasis in the amygdala, dendritic spine loss, reduced prefrontal dopaminergic activity, and disruption of the glutamatergic/GABAergic balance (<xref ref-type="bibr" rid="B183">Stodgell et al., 2006</xref>; <xref ref-type="bibr" rid="B41">Dufour-Rainfray et al., 2010</xref>; <xref ref-type="bibr" rid="B89">Kataoka et al., 2013</xref>; <xref ref-type="bibr" rid="B200">Wang et al., 2013</xref>; <xref ref-type="bibr" rid="B79">Jacob et al., 2014</xref>; <xref ref-type="bibr" rid="B188">Takuma et al., 2014</xref>; <xref ref-type="bibr" rid="B66">Hara et al., 2015</xref>; <xref ref-type="bibr" rid="B73">Iijima et al., 2016</xref>; <xref ref-type="bibr" rid="B118">Mahmood et al., 2018</xref>).</p>
<p>In more thorough studies of the mechanism of action, <xref ref-type="bibr" rid="B61">Go et al. (2012)</xref> found that rats exposed to valproic acid <italic>in utero</italic> presented enhanced proliferation of neural progenitors and delayed neurogenesis by upregulating <italic>Wnt1</italic> expression and activating the GSK-3β/β-catenin pathway, leading to macrocephaly. Another study found that valproic acid increased BDNF by two transcriptional mechanisms involving <italic>MeCP2</italic> and tissue plasminogen activator (tPA). This increase in BDNF is proposed to alter neurite outgrowth, impairing synapse formation (<xref ref-type="bibr" rid="B94">Ko et al., 2018</xref>). Finally, <xref ref-type="bibr" rid="B95">Kolozsi et al. (2009)</xref> observed a downregulation of <italic>NLGN3</italic> – a highly implicated autism risk gene involved in synapse formation – in both hippocampal and somatosensory cortex of valproate-exposed mice. Examples of other proposed environmentally modulated mechanisms of ASD risk exist, but the literature supporting valproic acid is an excellent example of the heterogeneous effects one environmental factor can induce. Further research is strongly needed to determine how the environment modulates ASD risk.</p>
<p>Clearly, epigenetics can have a profound impact on the transcriptome of an organism. Pathogenic variants in even one epigenetic-regulating gene or effects from the environment can cause widespread gene dysregulation. Epigenetic modulators can themselves be causative of disease, but they may also exacerbate or ameliorate the disease phenotype by influencing expression of risk genes. More genome-wide studies are needed to understand the common ASD epigenome, and whether certain epigenetic markings might be protective or detrimental to individuals who are genetically susceptible. In addition, more studies are needed to decipher epigenetics as a link between environmental risk factors and genetic susceptibility. There is a possibility that certain environmental factors could have protective epigenetic effects, providing potential avenues for therapy.</p>
</sec>
<sec id="S3.SS3">
<title>Sex-Linked Modifiers</title>
<p>It is well established that ASD affects males at much higher rates than females. The reasons for this are not yet completely clear. Some studies argue that differential expression between genders may result in an under-diagnosis of females, as males tend to present more external behavior (e.g., aggression or increased repetitive behavior) and females tend to present more internal behavior (e.g., depression and avoiding demands) (<xref ref-type="bibr" rid="B204">Werling and Geschwind, 2013</xref>). While this may contribute to the rates of diagnosis, other possibilities include that the female sex is protective and/or males are particularly vulnerable. This may be due to influence from hormones, genetics, or other unknown factors. The genetically heterogeneous nature of ASD makes it likely that all these elements are involved – sex bias varies drastically based on factors such as which CNVs are causative or which comorbidities are present, suggesting diverse means by which a sex bias may occur (<xref ref-type="bibr" rid="B3">Amiet et al., 2008</xref>; <xref ref-type="bibr" rid="B145">Polyak et al., 2015</xref>). Potential mechanisms of sex-specific modulation will be discussed briefly, although more thorough reviews are available elsewhere (<xref ref-type="bibr" rid="B46">Ferri et al., 2018</xref>).</p>
<p>Multiple studies argue that the female sex is protective toward ASD susceptibility (<xref ref-type="bibr" rid="B157">Robinson et al., 2013</xref>; <xref ref-type="bibr" rid="B141">Pinto et al., 2014</xref>). For example, the average mutational burden in diagnosed females is much higher than in males, suggesting that males have a lower mutational burden threshold (<xref ref-type="bibr" rid="B80">Jacquemont et al., 2014</xref>; <xref ref-type="bibr" rid="B36">Desachy et al., 2015</xref>). Another study by <xref ref-type="bibr" rid="B157">Robinson et al. (2013)</xref> investigated nearly 10,000 dizygotic autistic twin pairs and found that siblings of female probands had significantly worse symptoms than siblings of male probands. Many investigations have also found that unaffected mothers may carry the same mutation as their affected male children. One particularly well-documented example for this is the 15q11-13 duplication (<xref ref-type="bibr" rid="B31">Cook et al., 1997</xref>; <xref ref-type="bibr" rid="B169">Schroer et al., 1998</xref>; <xref ref-type="bibr" rid="B64">Gurrieri et al., 1999</xref>; <xref ref-type="bibr" rid="B19">Boyar et al., 2001</xref>). This region codes for GABA<sub><italic>A</italic></sub> receptors, which is supported by the observation of perturbed GABA signaling in ASD (<xref ref-type="bibr" rid="B2">Al-Otaish et al., 2018</xref>). The discovery that estrogens rescue ASD phenotypes in both zebrafish and mouse models of autism is an especially convincing piece of evidence for the female protective theory (<xref ref-type="bibr" rid="B117">Macrì et al., 2010</xref>; <xref ref-type="bibr" rid="B69">Hoffman et al., 2016</xref>).</p>
<p>It is also possible that the female sex is not protective, but males are particularly vulnerable. Three studies of gene expression patterns noted males generally had a higher expression of genes implicated in ASD, such as chromatin regulators and genes related to immune involvement (<xref ref-type="bibr" rid="B217">Ziats and Rennert, 2013</xref>; <xref ref-type="bibr" rid="B174">Shi et al., 2016</xref>; <xref ref-type="bibr" rid="B205">Werling et al., 2016</xref>). A study with rat models of ASD reported male-specific downregulation of <italic>MeCP2</italic> leading to abnormal glutamate activity, providing another potential mechanism for male-specific vulnerability (<xref ref-type="bibr" rid="B92">Kim et al., 2016</xref>). Interestingly, multiple studies have found decreased levels of aromatase – an enzyme that catalyzes the conversion of testosterone to estradiol – in the brains of adolescent ASD individuals (<xref ref-type="bibr" rid="B165">Sarachana et al., 2011</xref>; <xref ref-type="bibr" rid="B32">Crider et al., 2014</xref>). Decreased aromatase has also been associated with decreased RAR-related orphan receptor A (<italic>RORA</italic>), an ASD-associated gene that is oppositely regulated by male and female hormones (<xref ref-type="bibr" rid="B133">Nguyen et al., 2010</xref>; <xref ref-type="bibr" rid="B165">Sarachana et al., 2011</xref>). <xref ref-type="bibr" rid="B71">Hu et al. (2015)</xref> found a much stronger correlation between <italic>RORA</italic> expression and that of its targets in the cortex of male mice relative to female mice, suggesting that RORA-deficient males may have greater dysregulation of genes than females.</p>
<p>Of course, there may also be a combination of female-specific protective and male-specific deleterious effects. For example, <xref ref-type="bibr" rid="B84">Jung et al. (2018)</xref> recently assessed sexually dimorphic traits in a CHD8<sup>+/N2373<italic>K</italic></sup> mouse model of autism. While male mice demonstrated abnormal social behaviors such as isolation-induced self-grooming, female behavior was similar to controls. Neuronal excitability was also enhanced in males and suppressed in females. Transcriptomes were distinct, with female mice revealing an enrichment for ECM molecules, likely providing a protective effect.</p>
<p>A likely mechanism of divergent modulation is from differential effects of sex hormones, which have been hypothesized to play an important role in ASD pathology for both males and females (<xref ref-type="bibr" rid="B11">Baron-Cohen et al., 2005</xref>, <xref ref-type="bibr" rid="B10">2015</xref>; <xref ref-type="bibr" rid="B206">Whitehouse et al., 2010</xref>; <xref ref-type="bibr" rid="B198">Honk et al., 2011</xref>; <xref ref-type="bibr" rid="B46">Ferri et al., 2018</xref>). For example, testosterone and estrogen have been shown to have contrasting effects on the immune system (<xref ref-type="bibr" rid="B109">Lenz et al., 2013</xref>; <xref ref-type="bibr" rid="B161">Roved et al., 2017</xref>), which has been repeatedly shown to play a pathological role in ASD (<xref ref-type="bibr" rid="B45">Estes and McAllister, 2015</xref>; <xref ref-type="bibr" rid="B98">Koyama and Ikegaya, 2015</xref>; <xref ref-type="bibr" rid="B91">Kim et al., 2017</xref>; <xref ref-type="bibr" rid="B123">McCarthy and Wright, 2017</xref>; <xref ref-type="bibr" rid="B129">Nadeem et al., 2019</xref>). <xref ref-type="bibr" rid="B170">Schwarz et al. (2011)</xref> analyzed biomarkers from individuals with Asperger’s syndrome and found 24 male-specific and 17 female-specific hits, including many immune-related molecules. Spine density, another phenotype strongly implicated in autism (<xref ref-type="bibr" rid="B29">Comery et al., 1997</xref>; <xref ref-type="bibr" rid="B77">Irwin et al., 2001</xref>; <xref ref-type="bibr" rid="B72">Hutsler and Zhang, 2010</xref>; <xref ref-type="bibr" rid="B42">Durand et al., 2012</xref>; <xref ref-type="bibr" rid="B188">Takuma et al., 2014</xref>; <xref ref-type="bibr" rid="B190">Tang et al., 2014</xref>; <xref ref-type="bibr" rid="B113">Liu et al., 2017a</xref>, <xref ref-type="bibr" rid="B114">b</xref>; <xref ref-type="bibr" rid="B177">Soltani et al., 2017</xref>), is also affected by testosterone (<xref ref-type="bibr" rid="B67">Hatanaka et al., 2015</xref>). Key molecules involved in neurotransmission such as GABA, glutamate, serotonin, and BDNF are all implicated in ASD and modulated by sex hormones (<xref ref-type="bibr" rid="B92">Kim et al., 2016</xref>, p. 2; <xref ref-type="bibr" rid="B162">Saghazadeh and Rezaei, 2017</xref>; <xref ref-type="bibr" rid="B2">Al-Otaish et al., 2018</xref>; <xref ref-type="bibr" rid="B43">Edwards et al., 2018</xref>; <xref ref-type="bibr" rid="B46">Ferri et al., 2018</xref>; <xref ref-type="bibr" rid="B50">Garbarino et al., 2018</xref>; <xref ref-type="bibr" rid="B218">Zieminska et al., 2018</xref>). It is not yet clear whether the majority of differences between male and female presentation of ASD arise from differential regulatory actions of sex hormones or from other modifiers, but the presence of a sexually dimorphic phenotype is well established. Future research will likely elucidate a clearer picture of the identity and mechanisms of sex-specific modifiers.</p>
</sec>
</sec>
<sec id="S4">
<title>Clinical Implications and Future Perspectives</title>
<p>When autism was first described, it was hypothesized to be an environmentally caused disease. Decades of research have since revealed that autism is a highly heterogeneous and extremely complex genetic condition. Even though great progress had been made in identifying hundreds of risk genes, very little is known about the different types of modifiers that may exacerbate or ameliorate disease severity. Such modifiers could include epigenetics, sex-linked modifiers, CNVs, double-hit mutations, or environmental factors (see <xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Genetic modifiers in autism spectrum disorder. Autism is estimated to be 40–80% heritable. However, both genetic and non-genetic factors modulate the penetrance of risk genes, resulting in a highly heterogeneous disease phenotype for similar pathogenic variants. Examples of genetic modulators include CNV, epigenetics, and double-hit mutations. Examples of non-genetic modifiers include environmental exposures and sex-linked modifiers.</p>
</caption>
<graphic xlink:href="fncel-13-00385-g001"></graphic>
</fig>
<p>It may take many more decades of research before the scientific community has an accurate picture of how these modulators contribute to the etiology of ASD. However, this understanding is critical for the development of effective therapies. Due to the extremely diverse genetic phenotype of patients, personalized medicine may be a future avenue for maximally effective treatment. A condensed series of genetic tests – such as a microarray with identified risk loci – could be an expedient and cost-effective solution to determining genetic etiology. Alternatively, therapies may be developed to address convergent disease phenotypes that encompass multiple genetic etiologies, such as neuronal hyperexcitability and abnormal synaptic function. Autism research has come astonishingly far in just a half a century. There is much more work to be done, but continued investigation will eventually lead to a cohesive understanding of the interplay between causative genetic factors and disease modifiers in the etiology of ASD.</p>
</sec>
<sec id="S5">
<title>Author Contributions</title>
<p>LR contributed to writing the main text and gathering all references. AG-G contributed to editing the manuscript drafts and providing insight into structure and material that should be included.</p>
</sec>
<sec id="conf1">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by start-up funds from the Feinberg School of Medicine, Northwestern University.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acuna-Hidalgo</surname><given-names>R.</given-names></name><name><surname>Bo</surname><given-names>T.</given-names></name><name><surname>Kwint</surname><given-names>M. P.</given-names></name><name><surname>van de Vorst</surname><given-names>M.</given-names></name><name><surname>Pinelli</surname><given-names>M.</given-names></name><name><surname>Veltman</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Post-zygotic point mutations are an underrecognized source of <italic>De Novo</italic> genomic variation.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>97</volume>
<fpage>67</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2015.05.008</pub-id>
<pub-id pub-id-type="pmid">26054435</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Otaish</surname><given-names>H.</given-names></name><name><surname>Al-Ayadhi</surname><given-names>L.</given-names></name><name><surname>Bjørklund</surname><given-names>G.</given-names></name><name><surname>Chirumbolo</surname><given-names>S.</given-names></name><name><surname>Urbina</surname><given-names>M. A.</given-names></name><name><surname>El-Ansary</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder.</article-title>
<source/><italic>Metab. Brain Dis.</italic>
<volume>33</volume>
<fpage>843</fpage>–<lpage>854</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-018-0186-6</pub-id>
<pub-id pub-id-type="pmid">29397522</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amiet</surname><given-names>C.</given-names></name><name><surname>Gourfinkel-An</surname><given-names>I.</given-names></name><name><surname>Bouzamondo</surname><given-names>A.</given-names></name><name><surname>Tordjman</surname><given-names>S.</given-names></name><name><surname>Baulac</surname><given-names>M.</given-names></name><name><surname>Lechat</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta-analysis.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>64</volume>
<fpage>577</fpage>–<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2008.04.030</pub-id>
<pub-id pub-id-type="pmid">18565495</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>S. V.</given-names></name><name><surname>Ellis</surname><given-names>S. E.</given-names></name><name><surname>Bakulski</surname><given-names>K. M.</given-names></name><name><surname>Sheppard</surname><given-names>B.</given-names></name><name><surname>Croen</surname><given-names>L. A.</given-names></name><name><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Cross-tissue integration of genetic and epigenetic data offers insight into autism spectrum disorder.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>8</volume>:<issue>1011</issue>. <pub-id pub-id-type="doi">10.1038/s41467-017-00868-y</pub-id>
<pub-id pub-id-type="pmid">29066808</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artuso</surname><given-names>R.</given-names></name><name><surname>Papa</surname><given-names>F. T.</given-names></name><name><surname>Grillo</surname><given-names>E.</given-names></name><name><surname>Mucciolo</surname><given-names>M.</given-names></name><name><surname>Yasui</surname><given-names>D. H.</given-names></name><name><surname>Dunaway</surname><given-names>K. W.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Investigation of modifier genes within copy number variations in Rett syndrome.</article-title>
<source/><italic>J. Hum. Genet.</italic>
<volume>56</volume>
<fpage>508</fpage>–<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1038/jhg.2011.50</pub-id>
<pub-id pub-id-type="pmid">21593744</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auranen</surname><given-names>M.</given-names></name><name><surname>Vanhala</surname><given-names>R.</given-names></name><name><surname>Varilo</surname><given-names>T.</given-names></name><name><surname>Ayers</surname><given-names>K.</given-names></name><name><surname>Kempas</surname><given-names>E.</given-names></name><name><surname>Ylisaukko-oja</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>A genomewide screen for autism-spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25-27.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>71</volume>
<fpage>777</fpage>–<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1086/342720</pub-id>
<pub-id pub-id-type="pmid">12192642</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>T.</given-names></name><name><surname>Tomasini</surname><given-names>L.</given-names></name><name><surname>Mariani</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name><name><surname>Roychowdhury</surname><given-names>T.</given-names></name><name><surname>Franjic</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Different mutational rates and mechanisms in human cells at pregastrulation and neurogenesis.</article-title>
<source/><italic>Science</italic>
<volume>359</volume>
<fpage>550</fpage>–<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1126/science.aan8690</pub-id>
<pub-id pub-id-type="pmid">29217587</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>A.</given-names></name><name><surname>Le Couteur</surname><given-names>A.</given-names></name><name><surname>Gottesman</surname><given-names>I.</given-names></name><name><surname>Bolton</surname><given-names>P.</given-names></name><name><surname>Simonoff</surname><given-names>E.</given-names></name><name><surname>Yuzda</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>Autism as a strongly genetic disorder: evidence from a British twin study.</article-title>
<source/><italic>Psychol. Med.</italic>
<volume>25</volume>
<fpage>63</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1017/s0033291700028099</pub-id>
<pub-id pub-id-type="pmid">7792363</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barber</surname><given-names>J. C. K.</given-names></name><name><surname>Hall</surname><given-names>V.</given-names></name><name><surname>Maloney</surname><given-names>V. K.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Roberts</surname><given-names>A. M.</given-names></name><name><surname>Brady</surname><given-names>A. F.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>16p11.2–p12.2 duplication syndrome; a genomic condition differentiated from euchromatic variation of 16p11.2.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>21</volume>
<fpage>182</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2012.144</pub-id>
<pub-id pub-id-type="pmid">22828807</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron-Cohen</surname><given-names>S.</given-names></name><name><surname>Auyeung</surname><given-names>B.</given-names></name><name><surname>Nørgaard-Pedersen</surname><given-names>B.</given-names></name><name><surname>Hougaard</surname><given-names>D. M.</given-names></name><name><surname>Abdallah</surname><given-names>M. W.</given-names></name><name><surname>Melgaard</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Elevated fetal steroidogenic activity in autism.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>20</volume>
<fpage>369</fpage>–<lpage>376</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2014.48</pub-id>
<pub-id pub-id-type="pmid">24888361</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron-Cohen</surname><given-names>S.</given-names></name><name><surname>Knickmeyer</surname><given-names>R. C.</given-names></name><name><surname>Belmonte</surname><given-names>M. K.</given-names></name></person-group> (<year>2005</year>). <article-title>Sex differences in the brain: implications for explaining autism.</article-title>
<source/><italic>Science</italic>
<volume>310</volume>
<fpage>819</fpage>–<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1126/science.1115455</pub-id>
<pub-id pub-id-type="pmid">16272115</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>S.</given-names></name><name><surname>Beck</surname><given-names>J. C.</given-names></name><name><surname>Bernier</surname><given-names>R.</given-names></name><name><surname>Bisson</surname><given-names>E.</given-names></name><name><surname>Braun</surname><given-names>T. A.</given-names></name><name><surname>Casavant</surname><given-names>T. L.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>An autosomal genomic screen for autism. Collaborative linkage study of autism.</article-title>
<source/><italic>Am. J. Med. Genet.</italic>
<volume>88</volume>
<fpage>609</fpage>–<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1096-8628(19991215)88:6&lt;609::aid-ajmg7&gt;3.0.co;2-l</pub-id>
<pub-id pub-id-type="pmid">10581478</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behnia</surname><given-names>F.</given-names></name><name><surname>Parets</surname><given-names>S. E.</given-names></name><name><surname>Kechichian</surname><given-names>T.</given-names></name><name><surname>Yin</surname><given-names>H.</given-names></name><name><surname>Dutta</surname><given-names>E. H.</given-names></name><name><surname>Saade</surname><given-names>G. R.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Fetal DNA methylation of autism spectrum disorders candidate genes: association with spontaneous preterm birth.</article-title>
<source/><italic>Am. J. Obstet. Gynecol.</italic>
<volume>212</volume>:<issue>533.e1-e9</issue>. <pub-id pub-id-type="doi">10.1016/j.ajog.2015.02.011</pub-id>
<pub-id pub-id-type="pmid">25687563</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaker-Lee</surname><given-names>A.</given-names></name><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>McCammon</surname><given-names>J. M.</given-names></name><name><surname>De Rienzo</surname><given-names>G.</given-names></name><name><surname>Sive</surname><given-names>H.</given-names></name></person-group> (<year>2012</year>). <article-title>Zebrafish homologs of genes within 16p11.2, a genomic region associated with brain disorders, are active during brain development, and include two deletion dosage sensor genes.</article-title>
<source/><italic>Dis. Model. Mech.</italic>
<volume>5</volume>
<fpage>834</fpage>–<lpage>851</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.009944</pub-id>
<pub-id pub-id-type="pmid">22566537</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bölte</surname><given-names>S.</given-names></name><name><surname>Girdler</surname><given-names>S.</given-names></name><name><surname>Marschik</surname><given-names>P. B.</given-names></name></person-group> (<year>2019</year>). <article-title>The contribution of environmental exposure to the etiology of autism spectrum disorder.</article-title>
<source/><italic>Cell. Mol. Life Sci.</italic>
<volume>76</volume>
<fpage>1275</fpage>–<lpage>1297</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-018-2988-4</pub-id>
<pub-id pub-id-type="pmid">30570672</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolton</surname><given-names>P. F.</given-names></name><name><surname>Dennis</surname><given-names>N. R.</given-names></name><name><surname>Browne</surname><given-names>C. E.</given-names></name><name><surname>Thomas</surname><given-names>N. S.</given-names></name><name><surname>Veltman</surname><given-names>M. W. M.</given-names></name><name><surname>Thompson</surname><given-names>R. J.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>The phenotypic manifestations of interstitial duplications of proximal 15q with special reference to the autistic spectrum disorders.</article-title>
<source/><italic>Am. J. Med. Genet.</italic>
<volume>105</volume>
<fpage>675</fpage>–<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.1551</pub-id>
<pub-id pub-id-type="pmid">11803514</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnet-Brilhault</surname><given-names>F.</given-names></name><name><surname>Alirol</surname><given-names>S.</given-names></name><name><surname>Blanc</surname><given-names>R.</given-names></name><name><surname>Bazaud</surname><given-names>S.</given-names></name><name><surname>Marouillat</surname><given-names>S.</given-names></name><name><surname>Thépault</surname><given-names>R.-A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>GABA/Glutamate synaptic pathways targeted by integrative genomic and electrophysiological explorations distinguish autism from intellectual disability.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>21</volume>
<fpage>411</fpage>–<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.75</pub-id>
<pub-id pub-id-type="pmid">26055424</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourdon</surname><given-names>V.</given-names></name><name><surname>Philippe</surname><given-names>C.</given-names></name><name><surname>Bienvenu</surname><given-names>T.</given-names></name><name><surname>Koenig</surname><given-names>B.</given-names></name><name><surname>Tardieu</surname><given-names>M.</given-names></name><name><surname>Chelly</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Evidence of somatic mosaicism for a MECP2 mutation in females with Rett syndrome: diagnostic implications.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>38</volume>
<fpage>867</fpage>–<lpage>871</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.38.12.867</pub-id>
<pub-id pub-id-type="pmid">11768391</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyar</surname><given-names>F. Z.</given-names></name><name><surname>Whitney</surname><given-names>M. M.</given-names></name><name><surname>Lossie</surname><given-names>A. C.</given-names></name><name><surname>Gray</surname><given-names>B. A.</given-names></name><name><surname>Keller</surname><given-names>K. L.</given-names></name><name><surname>Stalker</surname><given-names>H. J.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>A family with a grand-maternally derived interstitial duplication of proximal 15q.</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>60</volume>
<fpage>421</fpage>–<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1034/j.1399-0004.2001.600604.x</pub-id>
<pub-id pub-id-type="pmid">11846734</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruder</surname><given-names>C. E. G.</given-names></name><name><surname>Piotrowski</surname><given-names>A.</given-names></name><name><surname>Gijsbers</surname><given-names>A. A. C. J.</given-names></name><name><surname>Andersson</surname><given-names>R.</given-names></name><name><surname>Erickson</surname><given-names>S.</given-names></name><name><surname>Diaz</surname></name><etal></etal></person-group> (<year>2008</year>). <article-title>Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>82</volume>
<fpage>763</fpage>–<lpage>771</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.12.011</pub-id>
<pub-id pub-id-type="pmid">18304490</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buxbaum</surname><given-names>J. D.</given-names></name><name><surname>Silverman</surname><given-names>J. M.</given-names></name><name><surname>Smith</surname><given-names>C. J.</given-names></name><name><surname>Kilifarski</surname><given-names>M.</given-names></name><name><surname>Reichert</surname><given-names>J.</given-names></name><name><surname>Hollander</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>68</volume>
<fpage>1514</fpage>–<lpage>1520</lpage>. <pub-id pub-id-type="doi">10.1086/320588</pub-id>
<pub-id pub-id-type="pmid">11353400</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carney</surname><given-names>R. M.</given-names></name><name><surname>Wolpert</surname><given-names>C. M.</given-names></name><name><surname>Ravan</surname><given-names>S. A.</given-names></name><name><surname>Shahbazian</surname><given-names>M.</given-names></name><name><surname>Ashley-Koch</surname><given-names>A.</given-names></name><name><surname>Cuccaro</surname><given-names>M. L.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Identification of MeCP2 mutations in a series of females with autistic disorder.</article-title>
<source/><italic>Pediatr. Neurol.</italic>
<volume>28</volume>
<fpage>205</fpage>–<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1016/s0887-8994(02)00624-0</pub-id>
<pub-id pub-id-type="pmid">12770674</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanova</surname><given-names>E. L.</given-names></name><name><surname>Sharp</surname><given-names>J. L.</given-names></name><name><surname>Chakraborty</surname><given-names>H.</given-names></name><name><surname>Sumi</surname><given-names>N. S.</given-names></name><name><surname>Casanova</surname><given-names>M. F.</given-names></name></person-group> (<year>2016</year>). <article-title>Genes with high penetrance for syndromic and non-syndromic autism typically function within the nucleus and regulate gene expression.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>7</volume>:<issue>18</issue>. <pub-id pub-id-type="doi">10.1186/s13229-016-0082-z</pub-id>
<pub-id pub-id-type="pmid">26985359</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castermans</surname><given-names>D.</given-names></name><name><surname>Thienpont</surname><given-names>B.</given-names></name><name><surname>Volders</surname><given-names>K.</given-names></name><name><surname>Crepel</surname><given-names>A.</given-names></name><name><surname>Vermeesch</surname><given-names>J. R.</given-names></name><name><surname>Schrander-Stumpel</surname><given-names>C. T.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Position effect leading to haploinsufficiency in a mosaic ring chromosome 14 in a boy with autism.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>16</volume>
<fpage>1187</fpage>–<lpage>1192</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2008.71</pub-id>
<pub-id pub-id-type="pmid">18414512</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>H.-T.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name><name><surname>Rosenmund</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number.</article-title>
<source/><italic>Neuron</italic>
<volume>56</volume>
<fpage>58</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.08.018</pub-id>
<pub-id pub-id-type="pmid">17920015</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaste</surname><given-names>P.</given-names></name><name><surname>Leboyer</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Autism risk factors: genes, environment, and gene-environment interactions.</article-title>
<source/><italic>Dialogues Clin. Neurosci.</italic>
<volume>14</volume>
<fpage>281</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="pmid">23226953</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>T.-L.</given-names></name><name><surname>Qiu</surname><given-names>Z.</given-names></name></person-group> (<year>2014</year>). <article-title>MeCP2: multifaceted roles in gene regulation and neural development.</article-title>
<source/><italic>Neurosci. Bull.</italic>
<volume>30</volume>
<fpage>601</fpage>–<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1007/s12264-014-1452-6</pub-id>
<pub-id pub-id-type="pmid">25082535</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clayton-Smith</surname><given-names>J.</given-names></name><name><surname>Watson</surname><given-names>P.</given-names></name><name><surname>Ramsden</surname><given-names>S.</given-names></name><name><surname>Black</surname><given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males.</article-title>
<source/><italic>Lancet</italic>
<volume>356</volume>
<fpage>830</fpage>–<lpage>832</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(00)02661-1</pub-id>
<pub-id pub-id-type="pmid">11022934</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comery</surname><given-names>T. A.</given-names></name><name><surname>Harris</surname><given-names>J. B.</given-names></name><name><surname>Willems</surname><given-names>P. J.</given-names></name><name><surname>Oostra</surname><given-names>B. A.</given-names></name><name><surname>Irwin</surname><given-names>S. A.</given-names></name><name><surname>Weiler</surname><given-names>I. J.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>94</volume>
<fpage>5401</fpage>–<lpage>5404</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.10.5401</pub-id>
<pub-id pub-id-type="pmid">9144249</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Constantino</surname><given-names>J. N.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Frazier</surname><given-names>T.</given-names></name><name><surname>Abbacchi</surname><given-names>A. M.</given-names></name><name><surname>Law</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Sibling recurrence and the genetic epidemiology of autism.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>167</volume>
<fpage>1349</fpage>–<lpage>1356</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2010.09101470</pub-id>
<pub-id pub-id-type="pmid">20889652</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>E. H.</given-names></name><name><surname>Lindgren</surname><given-names>V.</given-names></name><name><surname>Leventhal</surname><given-names>B. L.</given-names></name><name><surname>Courchesne</surname><given-names>R.</given-names></name><name><surname>Lincoln</surname><given-names>A.</given-names></name><name><surname>Shulman</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Autism or atypical autism in maternally but not paternally derived proximal 15q duplication.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>60</volume>
<fpage>928</fpage>–<lpage>934</lpage>. <pub-id pub-id-type="pmid">9106540</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crider</surname><given-names>A.</given-names></name><name><surname>Thakkar</surname><given-names>R.</given-names></name><name><surname>Ahmed</surname><given-names>A. O.</given-names></name><name><surname>Pillai</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Dysregulation of estrogen receptor beta (ERβ), aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjects.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>5</volume>:<issue>46</issue>. <pub-id pub-id-type="doi">10.1186/2040-2392-5-46</pub-id>
<pub-id pub-id-type="pmid">25221668</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><collab>Cross-Disorder Group of the Psychiatric Genomics Consortium</collab> (<year>2013</year>). <article-title>Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.</article-title>
<source/><italic>Lancet</italic>
<volume>381</volume>
<fpage>1371</fpage>–<lpage>1379</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(12)62129-1</pub-id>
<pub-id pub-id-type="pmid">23453885</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><collab>Cross-Disorder Group of the Psychiatric Genomics Consortium</collab>
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>S. H.</given-names></name><name><surname>Ripke</surname><given-names>S.</given-names></name><name><surname>Neale</surname><given-names>B. M.</given-names></name><name><surname>Faraone</surname><given-names>S. V.</given-names></name><name><surname>Purcell</surname><given-names>S. M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>45</volume>
<fpage>984</fpage>–<lpage>994</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2711</pub-id>
<pub-id pub-id-type="pmid">23933821</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Rubeis</surname><given-names>S.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Goldberg</surname><given-names>A. P.</given-names></name><name><surname>Poultney</surname><given-names>C. S.</given-names></name><name><surname>Samocha</surname><given-names>K.</given-names></name><name><surname>Cicek</surname><given-names>A. E.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Synaptic, transcriptional and chromatin genes disrupted in autism.</article-title>
<source/><italic>Nature</italic>
<volume>515</volume>
<fpage>209</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1038/nature13772</pub-id>
<pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desachy</surname><given-names>G.</given-names></name><name><surname>Croen</surname><given-names>L. A.</given-names></name><name><surname>Torres</surname><given-names>A. R.</given-names></name><name><surname>Kharrazi</surname><given-names>M.</given-names></name><name><surname>Delorenze</surname><given-names>G. N.</given-names></name><name><surname>Windham</surname><given-names>G. C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Increased female autosomal burden of rare copy number variants in human populations and in autism families.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>20</volume>
<fpage>170</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2014.179</pub-id>
<pub-id pub-id-type="pmid">25582617</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Gama</surname><given-names>A. M.</given-names></name><name><surname>Walsh</surname><given-names>C. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Somatic mosaicism and neurodevelopmental disease.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>21</volume>
<fpage>1504</fpage>–<lpage>1514</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0257-3</pub-id>
<pub-id pub-id-type="pmid">30349109</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Ye</surname><given-names>A. Y.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Postzygotic single-nucleotide mosaicisms contribute to the etiology of autism spectrum disorder and autistic traits and the origin of mutations.</article-title>
<source/><italic>Hum. Mutat.</italic>
<volume>38</volume>
<fpage>1002</fpage>–<lpage>1013</lpage>. <pub-id pub-id-type="doi">10.1002/humu.23255</pub-id>
<pub-id pub-id-type="pmid">28503910</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname><given-names>G. A.</given-names></name><name><surname>Crist</surname><given-names>R. C.</given-names></name><name><surname>Karatas</surname><given-names>E. T.</given-names></name><name><surname>Hammond</surname><given-names>M. J.</given-names></name><name><surname>Ewing</surname><given-names>A. D.</given-names></name><name><surname>Ferraro</surname><given-names>T. N.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Analysis of LINE-1 elements in DNA from postmortem brains of individuals with Schizophrenia.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>42</volume>
<fpage>2602</fpage>–<lpage>2611</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2017.115</pub-id>
<pub-id pub-id-type="pmid">28585566</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duffney</surname><given-names>L. J.</given-names></name><name><surname>Valdez</surname><given-names>P.</given-names></name><name><surname>Tremblay</surname><given-names>M. W.</given-names></name><name><surname>Cao</surname><given-names>X.</given-names></name><name><surname>Montgomery</surname><given-names>S.</given-names></name><name><surname>McConkie-Rosell</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Epigenetics and autism spectrum disorder: a report of an autism case with mutation in H1 linker histone HIST1H1E and literature review.</article-title>
<source/><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic>
<volume>177</volume>
<fpage>426</fpage>–<lpage>433</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32631</pub-id>
<pub-id pub-id-type="pmid">29704315</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dufour-Rainfray</surname><given-names>D.</given-names></name><name><surname>Vourc’h</surname><given-names>P.</given-names></name><name><surname>Le Guisquet</surname><given-names>A.-M.</given-names></name><name><surname>Garreau</surname><given-names>L.</given-names></name><name><surname>Ternant</surname><given-names>D.</given-names></name><name><surname>Bodard</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>470</volume>
<fpage>55</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2009.12.054</pub-id>
<pub-id pub-id-type="pmid">20036713</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>C. M.</given-names></name><name><surname>Perroy</surname><given-names>J.</given-names></name><name><surname>Loll</surname><given-names>F.</given-names></name><name><surname>Perrais</surname><given-names>D.</given-names></name><name><surname>Fagni</surname><given-names>L.</given-names></name><name><surname>Bourgeron</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>17</volume>
<fpage>71</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2011.57</pub-id>
<pub-id pub-id-type="pmid">21606927</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>K. A.</given-names></name><name><surname>Madden</surname><given-names>A. M. K.</given-names></name><name><surname>Zup</surname><given-names>S. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Serotonin receptor regulation as a potential mechanism for sexually dimorphic oxytocin dysregulation in a model of Autism.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1701</volume>
<fpage>85</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2018.07.020</pub-id>
<pub-id pub-id-type="pmid">30040918</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escamilla</surname><given-names>C. O.</given-names></name><name><surname>Filonova</surname><given-names>I.</given-names></name><name><surname>Walker</surname><given-names>A. K.</given-names></name><name><surname>Xuan</surname><given-names>Z. X.</given-names></name><name><surname>Holehonnur</surname><given-names>R.</given-names></name><name><surname>Espinosa</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title><italic>Kctd13</italic> deletion reduces synaptic transmission via increased RhoA.</article-title>
<source/><italic>Nature</italic>
<volume>551</volume>
<fpage>227</fpage>–<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1038/nature24470</pub-id>
<pub-id pub-id-type="pmid">29088697</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estes</surname><given-names>M. L.</given-names></name><name><surname>McAllister</surname><given-names>A. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Immune mediators in the brain and peripheral tissues in autism spectrum disorder.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>16</volume>
<fpage>469</fpage>–<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3978</pub-id>
<pub-id pub-id-type="pmid">26189694</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferri</surname><given-names>S. L.</given-names></name><name><surname>Abel</surname><given-names>T.</given-names></name><name><surname>Brodkin</surname><given-names>E. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Sex differences in autism spectrum disorder: a review.</article-title>
<source/><italic>Curr. Psychiatry Rep.</italic>
<volume>20</volume>:<issue>9</issue>. <pub-id pub-id-type="doi">10.1007/s11920-018-0874-2</pub-id>
<pub-id pub-id-type="pmid">29504047</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>E.</given-names></name><name><surname>Scambler</surname><given-names>P.</given-names></name></person-group> (<year>1994</year>). <article-title>Human haploinsufficiency — one for sorrow, two for joy.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>7</volume>
<fpage>5</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/ng0594-5</pub-id>
<pub-id pub-id-type="pmid">8075640</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folstein</surname><given-names>S.</given-names></name><name><surname>Rutter</surname><given-names>M.</given-names></name></person-group> (<year>1977</year>). <article-title>Genetic influences and infantile autism.</article-title>
<source/><italic>Nature</italic>
<volume>265</volume>
<fpage>726</fpage>–<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1038/265726a0</pub-id>
<pub-id pub-id-type="pmid">558516</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freed</surname><given-names>D.</given-names></name><name><surname>Pevsner</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>The contribution of mosaic variants to autism spectrum disorder.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>12</volume>:<issue>e1006245</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1006245</pub-id>
<pub-id pub-id-type="pmid">27632392</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garbarino</surname><given-names>V. R.</given-names></name><name><surname>Gilman</surname><given-names>T. L.</given-names></name><name><surname>Daws</surname><given-names>L. C.</given-names></name><name><surname>Gould</surname><given-names>G. G.</given-names></name></person-group> (<year>2018</year>). <article-title>Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder.</article-title>
<source/><italic>Pharmacol. Res.</italic>
<volume>140</volume>
<fpage>85</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2018.07.010</pub-id>
<pub-id pub-id-type="pmid">30009933</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardener</surname><given-names>H.</given-names></name><name><surname>Spiegelman</surname><given-names>D.</given-names></name><name><surname>Buka</surname><given-names>S. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Prenatal risk factors for autism: a comprehensive meta-analysis.</article-title>
<source/><italic>Br. J. Psychiatry J. Ment. Sci.</italic>
<volume>195</volume>
<fpage>7</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.bp.108.051672</pub-id>
<pub-id pub-id-type="pmid">19567888</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Genetics of autism spectrum disorders.</article-title>
<source/><italic>Trends Cogn. Sci.</italic>
<volume>15</volume>
<fpage>409</fpage>–<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1016/j.tics.2011.07.003</pub-id>
<pub-id pub-id-type="pmid">21855394</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilissen</surname><given-names>C.</given-names></name><name><surname>Hehir-Kwa</surname><given-names>J. Y.</given-names></name><name><surname>Thung</surname><given-names>D. T.</given-names></name><name><surname>van de Vorst</surname><given-names>M.</given-names></name><name><surname>van Bon</surname><given-names>B. W. M.</given-names></name><name><surname>Willemsen</surname><given-names>M. H.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Genome sequencing identifies major causes of severe intellectual disability.</article-title>
<source/><italic>Nature</italic>
<volume>511</volume>
<fpage>344</fpage>–<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1038/nature13394</pub-id>
<pub-id pub-id-type="pmid">24896178</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillberg</surname><given-names>C.</given-names></name><name><surname>Wahlström</surname><given-names>J.</given-names></name></person-group> (<year>1985</year>). <article-title>Chromosome abnormalities in infantile autism and other childhood psychoses: a population study of 66 cases.</article-title>
<source/><italic>Dev. Med. Child Neurol.</italic>
<volume>27</volume>
<fpage>293</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8749.1985.tb04539.x</pub-id>
<pub-id pub-id-type="pmid">3160621</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giovedí</surname><given-names>S.</given-names></name><name><surname>Corradi</surname><given-names>A.</given-names></name><name><surname>Fassio</surname><given-names>A.</given-names></name><name><surname>Benfenati</surname><given-names>F.</given-names></name></person-group> (<year>2014</year>). <article-title>Involvement of synaptic genes in the pathogenesis of autism spectrum disorders: the case of synapsins.</article-title>
<source/><italic>Front. Pediatr.</italic>
<volume>2</volume>:<issue>94</issue>. <pub-id pub-id-type="doi">10.3389/fped.2014.00094</pub-id>
<pub-id pub-id-type="pmid">25237665</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Dennis</surname><given-names>M. Y.</given-names></name><name><surname>Baker</surname><given-names>C.</given-names></name><name><surname>Malig</surname><given-names>M.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Campbell</surname><given-names>C. D.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>92</volume>
<fpage>221</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.12.016</pub-id>
<pub-id pub-id-type="pmid">23375656</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Rosenfeld</surname><given-names>J. A.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Parikh</surname><given-names>S.</given-names></name><name><surname>Friedman</surname><given-names>N.</given-names></name><name><surname>Goldstein</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Phenotypic heterogeneity of genomic disorders and rare copy-number variants.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>367</volume>
<fpage>1321</fpage>–<lpage>1331</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1200395</pub-id>
<pub-id pub-id-type="pmid">22970919</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Rosenfeld</surname><given-names>J. A.</given-names></name><name><surname>Cooper</surname><given-names>G. M.</given-names></name><name><surname>Antonacci</surname><given-names>F.</given-names></name><name><surname>Siswara</surname><given-names>P.</given-names></name><name><surname>Itsara</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>42</volume>
<fpage>203</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1038/ng.534</pub-id>
<pub-id pub-id-type="pmid">20154674</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glessner</surname><given-names>J. T.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>March</surname><given-names>M.</given-names></name><name><surname>Lima</surname><given-names>L.</given-names></name><name><surname>Desai</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Copy number variation meta-analysis reveals a novel duplication at 9p24 associated with multiple neurodevelopmental disorders.</article-title>
<source/><italic>Genome Med.</italic>
<volume>9</volume>:<issue>106</issue>. <pub-id pub-id-type="doi">10.1186/s13073-017-0494-1</pub-id>
<pub-id pub-id-type="pmid">29241461</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glessner</surname><given-names>J. T.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Cai</surname><given-names>G.</given-names></name><name><surname>Korvatska</surname><given-names>O.</given-names></name><name><surname>Kim</surname><given-names>C. E.</given-names></name><name><surname>Wood</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Autism genome-wide copy number variation reveals ubiquitin and neuronal genes.</article-title>
<source/><italic>Nature</italic>
<volume>459</volume>
<fpage>569</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1038/nature07953</pub-id>
<pub-id pub-id-type="pmid">19404257</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Go</surname><given-names>H. S.</given-names></name><name><surname>Kim</surname><given-names>K. C.</given-names></name><name><surname>Choi</surname><given-names>C. S.</given-names></name><name><surname>Jeon</surname><given-names>S. J.</given-names></name><name><surname>Kwon</surname><given-names>K. J.</given-names></name><name><surname>Han</surname><given-names>S.-H.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3β/β-catenin pathway.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>63</volume>
<fpage>1028</fpage>–<lpage>1041</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.07.028</pub-id>
<pub-id pub-id-type="pmid">22841957</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golzio</surname><given-names>C.</given-names></name><name><surname>Willer</surname><given-names>J.</given-names></name><name><surname>Talkowski</surname><given-names>M. E.</given-names></name><name><surname>Oh</surname><given-names>E. C.</given-names></name><name><surname>Taniguchi</surname><given-names>Y.</given-names></name><name><surname>Jacquemont</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant.</article-title>
<source/><italic>Nature</italic>
<volume>485</volume>
<fpage>363</fpage>–<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1038/nature11091</pub-id>
<pub-id pub-id-type="pmid">22596160</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guffanti</surname><given-names>G.</given-names></name><name><surname>Lievers</surname><given-names>L. S.</given-names></name><name><surname>Bonati</surname><given-names>M. T.</given-names></name><name><surname>Marchi</surname><given-names>M.</given-names></name><name><surname>Geronazzo</surname><given-names>L.</given-names></name><name><surname>Nardocci</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Role of UBE3A and ATP10A genes in autism susceptibility region 15q11-q13 in an Italian population: a positive replication for UBE3A.</article-title>
<source/><italic>Psychiatry Res.</italic>
<volume>185</volume>
<fpage>33</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2010.04.057</pub-id>
<pub-id pub-id-type="pmid">20609483</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurrieri</surname><given-names>F.</given-names></name><name><surname>Battaglia</surname><given-names>A.</given-names></name><name><surname>Torrisi</surname><given-names>L.</given-names></name><name><surname>Tancredi</surname><given-names>R.</given-names></name><name><surname>Cavallaro</surname><given-names>C.</given-names></name><name><surname>Sangiorgi</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Pervasive developmental disorder and epilepsy due to maternally derived duplication of 15q11-q13.</article-title>
<source/><italic>Neurology</italic>
<volume>52</volume>
<fpage>1694</fpage>–<lpage>1697</lpage>. <pub-id pub-id-type="pmid">10331703</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>A. M.</given-names></name><name><surname>Oh</surname><given-names>W. C.</given-names></name><name><surname>Vega-Ramirez</surname><given-names>H.</given-names></name><name><surname>Stein</surname><given-names>I. S.</given-names></name><name><surname>Hell</surname><given-names>J. W.</given-names></name><name><surname>Patrick</surname><given-names>G. N.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Activity-dependent growth of new dendritic spines is regulated by the proteasome.</article-title>
<source/><italic>Neuron</italic>
<volume>74</volume>
<fpage>1023</fpage>–<lpage>1030</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.04.031</pub-id>
<pub-id pub-id-type="pmid">22726833</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>Y.</given-names></name><name><surname>Takuma</surname><given-names>K.</given-names></name><name><surname>Takano</surname><given-names>E.</given-names></name><name><surname>Katashiba</surname><given-names>K.</given-names></name><name><surname>Taruta</surname><given-names>A.</given-names></name><name><surname>Higashino</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model.</article-title>
<source/><italic>Behav. Brain Res.</italic>
<volume>289</volume>
<fpage>39</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2015.04.022</pub-id>
<pub-id pub-id-type="pmid">25907743</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatanaka</surname><given-names>Y.</given-names></name><name><surname>Wada</surname><given-names>K.</given-names></name><name><surname>Kabuta</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>Abnormal instability, excess density, and aberrant morphology of dendritic spines in prenatally testosterone-exposed mice.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>85–86</volume>
<fpage>53</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2015.04.008</pub-id>
<pub-id pub-id-type="pmid">25953664</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havlovicova</surname><given-names>M.</given-names></name><name><surname>Novotna</surname><given-names>D.</given-names></name><name><surname>Kocarek</surname><given-names>E.</given-names></name><name><surname>Novotna</surname><given-names>K.</given-names></name><name><surname>Bendova</surname><given-names>S.</given-names></name><name><surname>Petrak</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>A girl with neurofibromatosis type 1, atypical autism and mosaic ring chromosome 17.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>143A</volume>
<fpage>76</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31569</pub-id>
<pub-id pub-id-type="pmid">17163520</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>E. J.</given-names></name><name><surname>Turner</surname><given-names>K. J.</given-names></name><name><surname>Fernandez</surname><given-names>J. M.</given-names></name><name><surname>Cifuentes</surname><given-names>D.</given-names></name><name><surname>Ghosh</surname><given-names>M.</given-names></name><name><surname>Ijaz</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Estrogens suppress a behavioral phenotype in Zebrafish mutants of the autism risk gene, CNTNAP2.</article-title>
<source/><italic>Neuron</italic>
<volume>89</volume>
<fpage>725</fpage>–<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.12.039</pub-id>
<pub-id pub-id-type="pmid">26833134</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horev</surname><given-names>G.</given-names></name><name><surname>Ellegood</surname><given-names>J.</given-names></name><name><surname>Lerch</surname><given-names>J. P.</given-names></name><name><surname>Son</surname><given-names>Y.-E. E.</given-names></name><name><surname>Muthuswamy</surname><given-names>L.</given-names></name><name><surname>Vogel</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>108</volume>
<fpage>17076</fpage>–<lpage>17081</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1114042108</pub-id>
<pub-id pub-id-type="pmid">21969575</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>V. W.</given-names></name><name><surname>Sarachana</surname><given-names>T.</given-names></name><name><surname>Sherrard</surname><given-names>R. M.</given-names></name><name><surname>Kocher</surname><given-names>K. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Investigation of sex differences in the expression of RORA and its transcriptional targets in the brain as a potential contributor to the sex bias in autism.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>6</volume>:<issue>7</issue>. <pub-id pub-id-type="doi">10.1186/2040-2392-6-7</pub-id>
<pub-id pub-id-type="pmid">26056561</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutsler</surname><given-names>J. J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1309</volume>
<fpage>83</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2009.09.120</pub-id>
<pub-id pub-id-type="pmid">19896929</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iijima</surname><given-names>Y.</given-names></name><name><surname>Behr</surname><given-names>K.</given-names></name><name><surname>Iijima</surname><given-names>T.</given-names></name><name><surname>Biemans</surname><given-names>B.</given-names></name><name><surname>Bischofberger</surname><given-names>J.</given-names></name><name><surname>Scheiffele</surname><given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>Distinct defects in synaptic differentiation of neocortical neurons in response to prenatal valproate exposure.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>6</volume>:<issue>27400</issue>. <pub-id pub-id-type="doi">10.1038/srep27400</pub-id>
<pub-id pub-id-type="pmid">27264355</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><collab>IMGSAC</collab> (<year>1998</year>). <article-title>Full genome screen for autism with evidence for linkage to a region on chromosome 7q | human molecular genetics | oxford academic.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>7</volume>
<fpage>571</fpage>–<lpage>578</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/7.3.571</pub-id>
<pub-id pub-id-type="pmid">9546821</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><collab>International Molecular Genetic Study of Autism Consortium [IMGSAC]</collab> (<year>2001</year>). <article-title>A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>69</volume>
<fpage>570</fpage>–<lpage>581</lpage>. <pub-id pub-id-type="doi">10.1086/323264</pub-id>
<pub-id pub-id-type="pmid">11481586</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>The contribution of <italic>de novo</italic> coding mutations to autism spectrum disorder.</article-title>
<source/><italic>Nature</italic>
<volume>515</volume>
<fpage>216</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1038/nature13908</pub-id>
<pub-id pub-id-type="pmid">25363768</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irwin</surname><given-names>S. A.</given-names></name><name><surname>Patel</surname><given-names>B.</given-names></name><name><surname>Idupulapati</surname><given-names>M.</given-names></name><name><surname>Harris</surname><given-names>J. B.</given-names></name><name><surname>Crisostomo</surname><given-names>R. A.</given-names></name><name><surname>Larsen</surname><given-names>B. P.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination.</article-title>
<source/><italic>Am. J. Med. Genet.</italic>
<volume>98</volume>
<fpage>161</fpage>–<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1002/1096-8628(20010115)98:2&lt;161:AID-AJMG1025&gt;3.0.CO;2-B</pub-id>
<pub-id pub-id-type="pmid">11223852</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>J.</given-names></name><name><surname>Singh</surname><given-names>M. D.</given-names></name><name><surname>Jensen</surname><given-names>M.</given-names></name><name><surname>Patel</surname><given-names>P.</given-names></name><name><surname>Pizzo</surname><given-names>L.</given-names></name><name><surname>Huber</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Pervasive genetic interactions modulate neurodevelopmental defects of the autism-associated 16p11.2 deletion in <italic>Drosophila melanogaster</italic>.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>9</volume>:<issue>2548</issue>. <pub-id pub-id-type="doi">10.1038/s41467-018-04882-6</pub-id>
<pub-id pub-id-type="pmid">29959322</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>J.</given-names></name><name><surname>Ribes</surname><given-names>V.</given-names></name><name><surname>Moore</surname><given-names>S.</given-names></name><name><surname>Constable</surname><given-names>S. C.</given-names></name><name><surname>Sasai</surname><given-names>N.</given-names></name><name><surname>Gerety</surname><given-names>S. S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Valproic acid silencing of ascl1b/Ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndrome.</article-title>
<source/><italic>Dis. Model. Mech.</italic>
<volume>7</volume>
<fpage>107</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.013219</pub-id>
<pub-id pub-id-type="pmid">24135485</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacquemont</surname><given-names>S.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Hersch</surname><given-names>M.</given-names></name><name><surname>Duyzend</surname><given-names>M. H.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Bergmann</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>A higher mutational burden in females supports a “female protective model” in neurodevelopmental disorders.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>94</volume>
<fpage>415</fpage>–<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2014.02.001</pub-id>
<pub-id pub-id-type="pmid">24581740</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamain</surname><given-names>S.</given-names></name><name><surname>Quach</surname><given-names>H.</given-names></name><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Råstam</surname><given-names>M.</given-names></name><name><surname>Colineaux</surname><given-names>C.</given-names></name><name><surname>Gillberg</surname><given-names>I. C.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>34</volume>
<fpage>27</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1038/ng1136</pub-id>
<pub-id pub-id-type="pmid">12669065</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>S. J.</given-names></name><name><surname>Shpyleva</surname><given-names>S.</given-names></name><name><surname>Melnyk</surname><given-names>S.</given-names></name><name><surname>Pavliv</surname><given-names>O.</given-names></name><name><surname>Pogribny</surname><given-names>I. P.</given-names></name></person-group> (<year>2013</year>). <article-title>Complex epigenetic regulation of Engrailed-2 (EN-2) homeobox gene in the autism cerebellum.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>3</volume>:<issue>e232</issue>. <pub-id pub-id-type="doi">10.1038/tp.2013.8</pub-id>
<pub-id pub-id-type="pmid">23423141</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y.-H.</given-names></name><name><surname>Sahoo</surname><given-names>T.</given-names></name><name><surname>Michaelis</surname><given-names>R. C.</given-names></name><name><surname>Bercovich</surname><given-names>D.</given-names></name><name><surname>Bressler</surname><given-names>J.</given-names></name><name><surname>Kashork</surname><given-names>C. D.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>131</volume>
<fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.30297</pub-id>
<pub-id pub-id-type="pmid">15389703</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>H.</given-names></name><name><surname>Park</surname><given-names>H.</given-names></name><name><surname>Choi</surname><given-names>Y.</given-names></name><name><surname>Kang</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>E.</given-names></name><name><surname>Kweon</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Sexually dimorphic behavior, neuronal activity, and gene expression in Chd8-mutant mice.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>21</volume>
<fpage>1218</fpage>–<lpage>1228</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0208-z</pub-id>
<pub-id pub-id-type="pmid">30104731</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kakinuma</surname><given-names>H.</given-names></name><name><surname>Ozaki</surname><given-names>M.</given-names></name><name><surname>Sato</surname><given-names>H.</given-names></name><name><surname>Takahashi</surname><given-names>H.</given-names></name></person-group> (<year>2008</year>). <article-title>Variation in GABA-A subunit gene copy number in an autistic patient with mosaic 4 p duplication (p12p16).</article-title>
<source/><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic>
<volume>147B</volume>
<fpage>973</fpage>–<lpage>975</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30663</pub-id>
<pub-id pub-id-type="pmid">18163449</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalsner</surname><given-names>L.</given-names></name><name><surname>Chamberlain</surname><given-names>S. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Prader-Willi, Angelman, and 15q11-q13 duplication syndromes.</article-title>
<source/><italic>Pediatr. Clin. North Am.</italic>
<volume>62</volume>
<fpage>587</fpage>–<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1016/j.pcl.2015.03.004</pub-id>
<pub-id pub-id-type="pmid">26022164</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanner</surname><given-names>L.</given-names></name></person-group> (<year>1943</year>). <article-title>Autistic disturbances of affective contact.</article-title>
<source/><italic>Nerv. Child</italic>
<volume>2</volume>
<fpage>217</fpage>–<lpage>250</lpage>.</mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karimi</surname><given-names>P.</given-names></name><name><surname>Kamali</surname><given-names>E.</given-names></name><name><surname>Mousavi</surname><given-names>S. M.</given-names></name><name><surname>Karahmadi</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Environmental factors influencing the risk of autism.</article-title>
<source/><italic>J. Res. Med. Sci.</italic>
<volume>22</volume>:<issue>27</issue>. <pub-id pub-id-type="doi">10.4103/1735-1995.200272</pub-id>
<pub-id pub-id-type="pmid">28413424</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataoka</surname><given-names>S.</given-names></name><name><surname>Takuma</surname><given-names>K.</given-names></name><name><surname>Hara</surname><given-names>Y.</given-names></name><name><surname>Maeda</surname><given-names>Y.</given-names></name><name><surname>Ago</surname><given-names>Y.</given-names></name><name><surname>Matsuda</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid.</article-title>
<source/><italic>Int. J. Neuropsychopharmacol.</italic>
<volume>16</volume>
<fpage>91</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1017/S1461145711001714</pub-id>
<pub-id pub-id-type="pmid">22093185</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khanzada</surname><given-names>N. S.</given-names></name><name><surname>Butler</surname><given-names>M. G.</given-names></name><name><surname>Manzardo</surname><given-names>A. M.</given-names></name></person-group> (<year>2017</year>). <article-title>GeneAnalytics pathway analysis and genetic overlap among autism spectrum disorder, bipolar disorder and schizophrenia.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>18</volume>:<issue>E527</issue>. <pub-id pub-id-type="doi">10.3390/ijms18030527</pub-id>
<pub-id pub-id-type="pmid">28264500</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.-J.</given-names></name><name><surname>Cho</surname><given-names>M.-H.</given-names></name><name><surname>Shim</surname><given-names>W. H.</given-names></name><name><surname>Kim</surname><given-names>J. K.</given-names></name><name><surname>Jeon</surname><given-names>E.-Y.</given-names></name><name><surname>Kim</surname><given-names>D.-H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>22</volume>
<fpage>1576</fpage>–<lpage>1584</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.103</pub-id>
<pub-id pub-id-type="pmid">27400854</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K. C.</given-names></name><name><surname>Choi</surname><given-names>C. S.</given-names></name><name><surname>Kim</surname><given-names>J.-W.</given-names></name><name><surname>Han</surname><given-names>S.-H.</given-names></name><name><surname>Cheong</surname><given-names>J. H.</given-names></name><name><surname>Ryu</surname><given-names>J. H.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>MeCP2 modulates sex differences in the postsynaptic development of the valproate animal model of autism.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>53</volume>
<fpage>40</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-014-8987-z</pub-id>
<pub-id pub-id-type="pmid">25404090</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knudson</surname><given-names>A. G.</given-names></name></person-group> (<year>1971</year>). <article-title>Mutation and cancer: statistical study of retinoblastoma.</article-title>
<source/><italic>PNAS</italic>
<volume>68</volume>
<fpage>820</fpage>–<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.68.4.820</pub-id>
<pub-id pub-id-type="pmid">5279523</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>H. M.</given-names></name><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Park</surname><given-names>H. H.</given-names></name><name><surname>Lee</surname><given-names>J. H.</given-names></name><name><surname>Jung</surname><given-names>S. H.</given-names></name><name><surname>Choi</surname><given-names>S. Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Dual mechanisms for the regulation of brain-derived neurotrophic factor by valproic acid in neural progenitor cells.</article-title>
<source/><italic>Korean J. Physiol. Pharmacol.</italic>
<volume>22</volume>
<fpage>679</fpage>–<lpage>688</lpage>. <pub-id pub-id-type="doi">10.4196/kjpp.2018.22.6.679</pub-id>
<pub-id pub-id-type="pmid">30402028</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolozsi</surname><given-names>E.</given-names></name><name><surname>Mackenzie</surname><given-names>R. N.</given-names></name><name><surname>Roullet</surname><given-names>F. I.</given-names></name><name><surname>deCatanzaro</surname><given-names>D.</given-names></name><name><surname>Foster</surname><given-names>J. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice.</article-title>
<source/><italic>Neuroscience</italic>
<volume>163</volume>
<fpage>1201</fpage>–<lpage>1210</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.07.021</pub-id>
<pub-id pub-id-type="pmid">19607885</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>A.</given-names></name><name><surname>Frigge</surname><given-names>M. L.</given-names></name><name><surname>Masson</surname><given-names>G.</given-names></name><name><surname>Besenbacher</surname><given-names>S.</given-names></name><name><surname>Sulem</surname><given-names>P.</given-names></name><name><surname>Magnusson</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Rate of <italic>de novo</italic> mutations and the importance of father’s age to disease risk.</article-title>
<source/><italic>Nature</italic>
<volume>488</volume>
<fpage>471</fpage>–<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1038/nature11396</pub-id>
<pub-id pub-id-type="pmid">22914163</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korb</surname><given-names>E.</given-names></name><name><surname>Herre</surname><given-names>M.</given-names></name><name><surname>Zucker-Scharff</surname><given-names>I.</given-names></name><name><surname>Gresack</surname><given-names>J.</given-names></name><name><surname>Allis</surname><given-names>C. D.</given-names></name><name><surname>Darnell</surname><given-names>R. B.</given-names></name></person-group> (<year>2017</year>). <article-title>Excess translation of epigenetic regulators contributes to fragile X syndrome and is alleviated by Brd4 inhibition.</article-title>
<source/><italic>Cell</italic>
<volume>170</volume>
<fpage>1209.e20</fpage>–<lpage>1223.e20</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.07.033</pub-id>
<pub-id pub-id-type="pmid">28823556</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koyama</surname><given-names>R.</given-names></name><name><surname>Ikegaya</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Microglia in the pathogenesis of autism spectrum disorders.</article-title>
<source/><italic>Neurosci. Res.</italic>
<volume>100</volume>
<fpage>1</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.neures.2015.06.005</pub-id>
<pub-id pub-id-type="pmid">26116891</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krebs</surname><given-names>M. O.</given-names></name><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Leroy</surname><given-names>S.</given-names></name><name><surname>Bourdel</surname><given-names>M. C.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name><name><surname>Leboyer</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Absence of association between a polymorphic GGC repeat in the 5’ untranslated region of the reelin gene and autism.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>7</volume>
<fpage>801</fpage>–<lpage>804</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001071</pub-id>
<pub-id pub-id-type="pmid">12192627</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krupp</surname><given-names>D. R.</given-names></name><name><surname>Barnard</surname><given-names>R. A.</given-names></name><name><surname>Duffourd</surname><given-names>Y.</given-names></name><name><surname>Evans</surname><given-names>S. A.</given-names></name><name><surname>Mulqueen</surname><given-names>R. M.</given-names></name><name><surname>Bernier</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Exonic mosaic mutations contribute risk for autism spectrum disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>101</volume>
<fpage>369</fpage>–<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2017.07.016</pub-id>
<pub-id pub-id-type="pmid">28867142</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubota</surname><given-names>T.</given-names></name><name><surname>Mochizuki</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Epigenetic effect of environmental factors on autism spectrum disorders.</article-title>
<source/><italic>Int. J. Environ. Res. Public. Health</italic>
<volume>13</volume>:<issue>E504</issue>. <pub-id pub-id-type="doi">10.3390/ijerph13050504</pub-id>
<pub-id pub-id-type="pmid">27187441</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>R. A.</given-names></name><name><surname>KaraMohamed</surname><given-names>S.</given-names></name><name><surname>Sudi</surname><given-names>J.</given-names></name><name><surname>Conrad</surname><given-names>D. F.</given-names></name><name><surname>Brune</surname><given-names>C.</given-names></name><name><surname>Badner</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Recurrent 16p11.2 microdeletions in autism.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>17</volume>
<fpage>628</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddm376</pub-id>
<pub-id pub-id-type="pmid">18156158</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunio</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Minakuchi</surname><given-names>Y.</given-names></name><name><surname>Ohori</surname><given-names>K.</given-names></name><name><surname>Soutome</surname><given-names>M.</given-names></name><name><surname>Hirasawa</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Comparison of genomic and epigenomic expression in monozygotic twins discordant for rett syndrome.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e66729</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0066729</pub-id>
<pub-id pub-id-type="pmid">23805272</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ladd-Acosta</surname><given-names>C.</given-names></name><name><surname>Hansen</surname><given-names>K. D.</given-names></name><name><surname>Briem</surname><given-names>E.</given-names></name><name><surname>Fallin</surname><given-names>M. D.</given-names></name><name><surname>Kaufmann</surname><given-names>W. E.</given-names></name><name><surname>Feinberg</surname><given-names>A. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Common DNA methylation alterations in multiple brain regions in autism.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>19</volume>
<fpage>862</fpage>–<lpage>871</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.114</pub-id>
<pub-id pub-id-type="pmid">23999529</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>M.-C.</given-names></name><name><surname>Lombardo</surname><given-names>M. V.</given-names></name><name><surname>Baron-Cohen</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Autism.</article-title>
<source/><italic>Lancet</italic>
<volume>383</volume>
<fpage>896</fpage>–<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)61539-1</pub-id><pub-id pub-id-type="pmid">24074734</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamb</surname><given-names>J. A.</given-names></name><name><surname>Parr</surname><given-names>J. R.</given-names></name><name><surname>Bailey</surname><given-names>A. J.</given-names></name><name><surname>Monaco</surname><given-names>A. P.</given-names></name></person-group> (<year>2002</year>). <article-title>Autism.</article-title>
<source/><italic>NeuroMol. Med.</italic>
<volume>2</volume>
<fpage>11</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1385/NMM:2:1:11</pub-id>
<pub-id pub-id-type="pmid">12230302</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leblond</surname><given-names>C. S.</given-names></name><name><surname>Heinrich</surname><given-names>J.</given-names></name><name><surname>Delorme</surname><given-names>R.</given-names></name><name><surname>Proepper</surname><given-names>C.</given-names></name><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Huguet</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>8</volume>:<issue>e1002521</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1002521</pub-id>
<pub-id pub-id-type="pmid">22346768</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S. Y.</given-names></name><name><surname>Ramirez</surname><given-names>J.</given-names></name><name><surname>Franco</surname><given-names>M.</given-names></name><name><surname>Lectez</surname><given-names>B.</given-names></name><name><surname>Gonzalez</surname><given-names>M.</given-names></name><name><surname>Barrio</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Ube3a, the E3 ubiquitin ligase causing Angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle Rpn10.</article-title>
<source/><italic>Cell. Mol. Life Sci.</italic>
<volume>71</volume>
<fpage>2747</fpage>–<lpage>2758</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-013-1526-7</pub-id>
<pub-id pub-id-type="pmid">24292889</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenz</surname><given-names>K. M.</given-names></name><name><surname>Nugent</surname><given-names>B. M.</given-names></name><name><surname>Haliyur</surname><given-names>R.</given-names></name><name><surname>McCarthy</surname><given-names>M. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Microglia are essential to masculinization of brain and behavior.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>
<fpage>2761</fpage>–<lpage>2772</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1268-12.2013</pub-id>
<pub-id pub-id-type="pmid">23407936</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Köhler</surname><given-names>U.</given-names></name><name><surname>Sharkey</surname><given-names>F. H.</given-names></name><name><surname>Menon</surname><given-names>D.</given-names></name><name><surname>Coulleaux</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Interstitial microduplication of Xp22.31: causative of intellectual disability or benign copy number variant?</article-title>
<source/><italic>Eur. J. Med. Genet.</italic>
<volume>53</volume>
<fpage>93</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2010.01.004</pub-id>
<pub-id pub-id-type="pmid">20132918</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>E. T.</given-names></name><name><surname>Uddin</surname><given-names>M.</given-names></name><name><surname>De Rubeis</surname><given-names>S.</given-names></name><name><surname>Chan</surname><given-names>Y.</given-names></name><name><surname>Kamumbu</surname><given-names>A. S.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>20</volume>
<fpage>1217</fpage>–<lpage>1224</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4598</pub-id>
<pub-id pub-id-type="pmid">28714951</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Nyholt</surname><given-names>D. R.</given-names></name><name><surname>Magnussen</surname><given-names>P.</given-names></name><name><surname>Parano</surname><given-names>E.</given-names></name><name><surname>Pavone</surname><given-names>P.</given-names></name><name><surname>Geschwind</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>A genomewide screen for autism susceptibility loci.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>69</volume>
<fpage>327</fpage>–<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1086/321980</pub-id>
<pub-id pub-id-type="pmid">11452361</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Yuan</surname><given-names>H.</given-names></name><name><surname>Vieira</surname><given-names>M.</given-names></name><name><surname>Sanz-Clemente</surname><given-names>A.</given-names></name><name><surname>Badger</surname><given-names>J. D.</given-names></name><etal></etal></person-group> (<year>2017a</year>). <article-title>A rare variant identified within the GluN2B C-Terminus in a patient with autism affects NMDA receptor surface expression and spine density.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>37</volume>
<fpage>4093</fpage>–<lpage>4102</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0827-16.2017</pub-id>
<pub-id pub-id-type="pmid">28283559</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Campanac</surname><given-names>E.</given-names></name><name><surname>Cheung</surname><given-names>H.-H.</given-names></name><name><surname>Ziats</surname><given-names>M. N.</given-names></name><name><surname>Canterel-Thouennon</surname><given-names>L.</given-names></name><name><surname>Raygada</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017b</year>). <article-title>Idiopathic autism: cellular and molecular phenotypes in pluripotent stem cell-derived neurons.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>54</volume>
<fpage>4507</fpage>–<lpage>4523</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-016-9961-8</pub-id>
<pub-id pub-id-type="pmid">27356918</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>J.-T.</given-names></name><name><surname>Cai</surname><given-names>Y.-J.</given-names></name><name><surname>Cheng</surname><given-names>T.-L.</given-names></name><name><surname>Cheng</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2.</article-title>
<source/><italic>Nature</italic>
<volume>530</volume>
<fpage>98</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1038/nature16533</pub-id>
<pub-id pub-id-type="pmid">26808898</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loomes</surname><given-names>R.</given-names></name><name><surname>Hull</surname><given-names>L.</given-names></name><name><surname>Mandy</surname><given-names>W. P. L.</given-names></name></person-group> (<year>2017</year>). <article-title>What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis.</article-title>
<source/><italic>J. Am. Acad. Child Adolesc. Psychiatry</italic>
<volume>56</volume>
<fpage>466</fpage>–<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaac.2017.03.013</pub-id>
<pub-id pub-id-type="pmid">28545751</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macrì</surname><given-names>S.</given-names></name><name><surname>Biamonte</surname><given-names>F.</given-names></name><name><surname>Romano</surname><given-names>E.</given-names></name><name><surname>Marino</surname><given-names>R.</given-names></name><name><surname>Keller</surname><given-names>F.</given-names></name><name><surname>Laviola</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>Perseverative responding and neuroanatomical alterations in adult heterozygous reeler mice are mitigated by neonatal estrogen administration.</article-title>
<source/><italic>Psychoneuroendocrinology</italic>
<volume>35</volume>
<fpage>1374</fpage>–<lpage>1387</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2010.03.012</pub-id>
<pub-id pub-id-type="pmid">20452127</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmood</surname><given-names>U.</given-names></name><name><surname>Ahn</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>E.-J.</given-names></name><name><surname>Choi</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Regan</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder.</article-title>
<source/><italic>Pharmacol. Res.</italic>
<volume>128</volume>
<fpage>110</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2017.08.006</pub-id>
<pub-id pub-id-type="pmid">28823725</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>C. R.</given-names></name><name><surname>Noor</surname><given-names>A.</given-names></name><name><surname>Vincent</surname><given-names>J. B.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Feuk</surname><given-names>L.</given-names></name><name><surname>Skaug</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Structural variation of chromosomes in autism spectrum disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>82</volume>
<fpage>477</fpage>–<lpage>488</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.12.009</pub-id>
<pub-id pub-id-type="pmid">18252227</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>C. R.</given-names></name><name><surname>Scherer</surname><given-names>S. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Detection and characterization of copy number variation in autism spectrum disorder.</article-title>
<source/><italic>Methods Mol. Biol.</italic>
<volume>838</volume>
<fpage>115</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61779-507-7_5</pub-id>
<pub-id pub-id-type="pmid">22228009</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>J.</given-names></name><name><surname>Cooper</surname><given-names>M.</given-names></name><name><surname>Hamshere</surname><given-names>M. L.</given-names></name><name><surname>Pocklington</surname><given-names>A.</given-names></name><name><surname>Scherer</surname><given-names>S. W.</given-names></name><name><surname>Kent</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Biological overlap of attention-deficit/hyperactivity disorder and autism spectrum disorder: evidence from copy number variants.</article-title>
<source/><italic>J. Am. Acad. Child Adolesc. Psychiatry</italic>
<volume>53</volume>
<fpage>761.e26</fpage>–<lpage>770.e26</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaac.2014.03.004</pub-id>
<pub-id pub-id-type="pmid">24954825</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCallion</surname><given-names>A. S.</given-names></name><name><surname>Stames</surname><given-names>E.</given-names></name><name><surname>Conlon</surname><given-names>R. A.</given-names></name><name><surname>Chakravarti</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Phenotype variation in two-locus mouse models of Hirschsprung disease: tissue-specific interaction between Ret and Ednrb.</article-title>
<source/><italic>PNAS</italic>
<volume>100</volume>
<fpage>1826</fpage>–<lpage>1831</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0337540100</pub-id>
<pub-id pub-id-type="pmid">12574515</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>M. M.</given-names></name><name><surname>Wright</surname><given-names>C. L.</given-names></name></person-group> (<year>2017</year>). <article-title>Convergence of sex differences and the neuroimmune system in autism spectrum disorder.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>81</volume>
<fpage>402</fpage>–<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2016.10.004</pub-id>
<pub-id pub-id-type="pmid">27871670</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>S. E.</given-names></name><name><surname>Gillis</surname><given-names>J.</given-names></name><name><surname>Kramer</surname><given-names>M.</given-names></name><name><surname>Lihm</surname><given-names>J.</given-names></name><name><surname>Yoon</surname><given-names>S.</given-names></name><name><surname>Berstein</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title><italic>De novo</italic> mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>19</volume>
<fpage>652</fpage>–<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2014.29</pub-id>
<pub-id pub-id-type="pmid">24776741</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaelson</surname><given-names>J. J.</given-names></name><name><surname>Shin</surname><given-names>M.-K.</given-names></name><name><surname>Koh</surname><given-names>J.-Y.</given-names></name><name><surname>Brueggeman</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>A.</given-names></name><name><surname>Katzman</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Neuronal PAS domain proteins 1 and 3 are master regulators of neuropsychiatric risk genes.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>82</volume>
<fpage>213</fpage>–<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.03.021</pub-id>
<pub-id pub-id-type="pmid">28499489</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modabbernia</surname><given-names>A.</given-names></name><name><surname>Velthorst</surname><given-names>E.</given-names></name><name><surname>Reichenberg</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>8</volume>:<issue>13</issue>. <pub-id pub-id-type="doi">10.1186/s13229-017-0121-4</pub-id>
<pub-id pub-id-type="pmid">28331572</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mor</surname><given-names>M.</given-names></name><name><surname>Nardone</surname><given-names>S.</given-names></name><name><surname>Sams</surname><given-names>D. S.</given-names></name><name><surname>Elliott</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>Hypomethylation of miR-142 promoter and upregulation of microRNAs that target the oxytocin receptor gene in the autism prefrontal cortex.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>6</volume>:<issue>46</issue>. <pub-id pub-id-type="doi">10.1186/s13229-015-0040-1</pub-id>
<pub-id pub-id-type="pmid">26273428</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulligan</surname><given-names>A.</given-names></name><name><surname>Anney</surname><given-names>R. J. L.</given-names></name><name><surname>O’Regan</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Butler</surname><given-names>L.</given-names></name><name><surname>Fitzgerald</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Autism symptoms in attention-deficit/hyperactivity disorder: a familial trait which correlates with conduct, oppositional defiant, language and motor disorders.</article-title>
<source/><italic>J. Autism Dev. Disord.</italic>
<volume>39</volume>
<fpage>197</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-008-0621-3</pub-id>
<pub-id pub-id-type="pmid">18642069</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadeem</surname><given-names>A.</given-names></name><name><surname>Ahmad</surname><given-names>S. F.</given-names></name><name><surname>Attia</surname><given-names>S. M.</given-names></name><name><surname>Al-Ayadhi</surname><given-names>L. Y.</given-names></name><name><surname>Al-Harbi</surname><given-names>N. O.</given-names></name><name><surname>Bakheet</surname><given-names>S. A.</given-names></name></person-group> (<year>2019</year>). <article-title>Dysregulated enzymatic antioxidant network in peripheral neutrophils and monocytes in children with autism.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>88</volume>
<fpage>352</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2018.08.020</pub-id>
<pub-id pub-id-type="pmid">30145184</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagarajan</surname><given-names>R. P.</given-names></name><name><surname>Hogart</surname><given-names>A. R.</given-names></name><name><surname>Gwye</surname><given-names>Y.</given-names></name><name><surname>Martin</surname><given-names>M. R.</given-names></name><name><surname>LaSalle</surname><given-names>J. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation.</article-title>
<source/><italic>Epigenetics</italic>
<volume>1</volume>
<fpage>e1</fpage>–<lpage>e11</lpage>. <pub-id pub-id-type="pmid">17486179</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagarajan</surname><given-names>R. P.</given-names></name><name><surname>Patzel</surname><given-names>K. A.</given-names></name><name><surname>Martin</surname><given-names>M.</given-names></name><name><surname>Yasui</surname><given-names>D. H.</given-names></name><name><surname>Swanberg</surname><given-names>S. E.</given-names></name><name><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>MECP2 promoter methylation and X chromosome inactivation in autism.</article-title>
<source/><italic>Autism Res.</italic>
<volume>1</volume>
<fpage>169</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1002/aur.24</pub-id>
<pub-id pub-id-type="pmid">19132145</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nardone</surname><given-names>S.</given-names></name><name><surname>Elliott</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>The interaction between the immune system and epigenetics in the etiology of autism spectrum disorders.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>10</volume>:<issue>329</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2016.00329</pub-id>
<pub-id pub-id-type="pmid">27462204</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>A.</given-names></name><name><surname>Rauch</surname><given-names>T. A.</given-names></name><name><surname>Pfeifer</surname><given-names>G. P.</given-names></name><name><surname>Hu</surname><given-names>V. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain.</article-title>
<source/><italic>FASEB J.</italic>
<volume>24</volume>
<fpage>3036</fpage>–<lpage>3051</lpage>. <pub-id pub-id-type="doi">10.1096/fj.10-154484</pub-id>
<pub-id pub-id-type="pmid">20375269</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijmeijer</surname><given-names>J. S.</given-names></name><name><surname>Arias-Vásquez</surname><given-names>A.</given-names></name><name><surname>Rommelse</surname><given-names>N. N. J.</given-names></name><name><surname>Altink</surname><given-names>M. E.</given-names></name><name><surname>Anney</surname><given-names>R. J. L.</given-names></name><name><surname>Asherson</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Identifying loci for the overlap between attention-deficit/hyperactivity disorder and autism spectrum disorder using a genome-wide QTL linkage approach.</article-title>
<source/><italic>J. Am. Acad. Child Adolesc. Psychiatry</italic>
<volume>49</volume>
<fpage>675</fpage>–<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaac.2010.03.015</pub-id>
<pub-id pub-id-type="pmid">20610137</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohkawara</surname><given-names>T.</given-names></name><name><surname>Katsuyama</surname><given-names>T.</given-names></name><name><surname>Ida-Eto</surname><given-names>M.</given-names></name><name><surname>Narita</surname><given-names>N.</given-names></name><name><surname>Narita</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Maternal viral infection during pregnancy impairs development of fetal serotonergic neurons.</article-title>
<source/><italic>Brain Dev.</italic>
<volume>37</volume>
<fpage>88</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2014.03.007</pub-id>
<pub-id pub-id-type="pmid">24780604</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>G.</given-names></name><name><surname>Matoso</surname><given-names>E.</given-names></name><name><surname>Vicente</surname><given-names>A.</given-names></name><name><surname>Ribeiro</surname><given-names>P.</given-names></name><name><surname>Marques</surname><given-names>C.</given-names></name><name><surname>Ataíde</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Partial tetrasomy of chromosome 3q and mosaicism in a child with autism.</article-title>
<source/><italic>J. Autism Dev. Disord.</italic>
<volume>33</volume>
<fpage>177</fpage>–<lpage>185</lpage>. <pub-id pub-id-type="pmid">12757357</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Karakoc</surname><given-names>E.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Sporadic autism exomes reveal a highly interconnected protein network of <italic>de novo</italic> mutations.</article-title>
<source/><italic>Nature</italic>
<volume>485</volume>
<fpage>246</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1038/nature10989</pub-id>
<pub-id pub-id-type="pmid">22495309</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papanikolaou</surname><given-names>K.</given-names></name><name><surname>Paliokosta</surname><given-names>E.</given-names></name><name><surname>Gyftodimou</surname><given-names>J.</given-names></name><name><surname>Kolaitis</surname><given-names>G.</given-names></name><name><surname>Vgenopoulou</surname><given-names>S.</given-names></name><name><surname>Sarri</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>A case of partial trisomy of chromosome 8p associated with autism.</article-title>
<source/><italic>J. Autism Dev. Disord.</italic>
<volume>36</volume>
<fpage>705</fpage>–<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-006-0104-3</pub-id>
<pub-id pub-id-type="pmid">16602035</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persico</surname><given-names>A. M.</given-names></name><name><surname>D’Agruma</surname><given-names>L.</given-names></name><name><surname>Maiorano</surname><given-names>N.</given-names></name><name><surname>Totaro</surname><given-names>A.</given-names></name><name><surname>Militerni</surname><given-names>R.</given-names></name><name><surname>Bravaccio</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>6</volume>
<fpage>150</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4000850</pub-id>
<pub-id pub-id-type="pmid">11317216</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>S. U.</given-names></name><name><surname>Beaudet</surname><given-names>A. L.</given-names></name><name><surname>Madduri</surname><given-names>N.</given-names></name><name><surname>Bacino</surname><given-names>C. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Autism in Angelman syndrome: implications for autism research.</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>66</volume>
<fpage>530</fpage>–<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2004.00362.x</pub-id>
<pub-id pub-id-type="pmid">15521981</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>D.</given-names></name><name><surname>Delaby</surname><given-names>E.</given-names></name><name><surname>Merico</surname><given-names>D.</given-names></name><name><surname>Barbosa</surname><given-names>M.</given-names></name><name><surname>Merikangas</surname><given-names>A.</given-names></name><name><surname>Klei</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>94</volume>
<fpage>677</fpage>–<lpage>694</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2014.03.018</pub-id>
<pub-id pub-id-type="pmid">24768552</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>D.</given-names></name><name><surname>Pagnamenta</surname><given-names>A. T.</given-names></name><name><surname>Klei</surname><given-names>L.</given-names></name><name><surname>Anney</surname><given-names>R.</given-names></name><name><surname>Merico</surname><given-names>D.</given-names></name><name><surname>Regan</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Functional impact of global rare copy number variation in autism spectrum disorders.</article-title>
<source/><italic>Nature</italic>
<volume>466</volume>
<fpage>368</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1038/nature09146</pub-id>
<pub-id pub-id-type="pmid">20531469</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzo</surname><given-names>L.</given-names></name><name><surname>Jensen</surname><given-names>M.</given-names></name><name><surname>Polyak</surname><given-names>A.</given-names></name><name><surname>Rosenfeld</surname><given-names>J. A.</given-names></name><name><surname>Mannik</surname><given-names>K.</given-names></name><name><surname>Krishnan</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants.</article-title>
<source/><italic>Genet. Med.</italic>
<volume>21</volume>
<fpage>816</fpage>–<lpage>825</lpage>. <pub-id pub-id-type="doi">10.1038/s41436-018-0266-3</pub-id>
<pub-id pub-id-type="pmid">30190612</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poduri</surname><given-names>A.</given-names></name><name><surname>Evrony</surname><given-names>G. D.</given-names></name><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Walsh</surname><given-names>C. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Somatic mutation, genomic variation, and neurological disease.</article-title>
<source/><italic>Science</italic>
<volume>341</volume>:<issue>1237758</issue>. <pub-id pub-id-type="doi">10.1126/science.1237758</pub-id>
<pub-id pub-id-type="pmid">23828942</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polyak</surname><given-names>A.</given-names></name><name><surname>Rosenfeld</surname><given-names>J. A.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>An assessment of sex bias in neurodevelopmental disorders.</article-title>
<source/><italic>Genome Med.</italic>
<volume>7</volume>:<issue>94</issue>. <pub-id pub-id-type="doi">10.1186/s13073-015-0216-215</pub-id>
<pub-id pub-id-type="pmid">26307204</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pucilowska</surname><given-names>J.</given-names></name><name><surname>Vithayathil</surname><given-names>J.</given-names></name><name><surname>Tavares</surname><given-names>E. J.</given-names></name><name><surname>Kelly</surname><given-names>C.</given-names></name><name><surname>Karlo</surname><given-names>J. C.</given-names></name><name><surname>Landreth</surname><given-names>G. E.</given-names></name></person-group> (<year>2015</year>). <article-title>The 16p11.2 deletion mouse model of autism exhibits altered cortical progenitor proliferation and brain cytoarchitecture linked to the <italic>ERK MAPK</italic> pathway.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>35</volume>
<fpage>3190</fpage>–<lpage>3200</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4864-13.2015</pub-id>
<pub-id pub-id-type="pmid">25698753</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puram</surname><given-names>S. V.</given-names></name><name><surname>Kim</surname><given-names>A. H.</given-names></name><name><surname>Park</surname><given-names>H.-Y.</given-names></name><name><surname>Anckar</surname><given-names>J.</given-names></name><name><surname>Bonni</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>The ubiquitin receptor S5a/Rpn10 links centrosomal proteasomes with dendrite development in the mammalian brain.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>4</volume>
<fpage>19</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.06.006</pub-id>
<pub-id pub-id-type="pmid">23831032</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>Z.-J.</given-names></name><name><surname>Hu</surname><given-names>Z.</given-names></name><name><surname>Matas</surname><given-names>E.</given-names></name><name><surname>Wei</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>21</volume>
<fpage>564</fpage>–<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0110-8</pub-id>
<pub-id pub-id-type="pmid">29531362</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>W.</given-names></name><name><surname>Chan</surname><given-names>J. A.</given-names></name><name><surname>Vinters</surname><given-names>H. V.</given-names></name><name><surname>Mathern</surname><given-names>G. W.</given-names></name><name><surname>Franz</surname><given-names>D. N.</given-names></name><name><surname>Taillon</surname><given-names>B. E.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2, and KRAS demonstrates that small second hit mutations in these genes are rare events.</article-title>
<source/><italic>Brain Pathol. Zurich Switz</italic>
<volume>20</volume>
<fpage>1096</fpage>–<lpage>1105</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-3639.2010.00416.x</pub-id>
<pub-id pub-id-type="pmid">20633017</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapoport</surname><given-names>J.</given-names></name><name><surname>Chavez</surname><given-names>A.</given-names></name><name><surname>Greenstein</surname><given-names>D.</given-names></name><name><surname>Addington</surname><given-names>A.</given-names></name><name><surname>Gogtay</surname><given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited.</article-title>
<source/><italic>J. Am. Acad. Child Adolesc. Psychiatry</italic>
<volume>48</volume>
<fpage>10</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1097/CHI.0b013e31818b1c63</pub-id>
<pub-id pub-id-type="pmid">19218893</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasalam</surname><given-names>A. D.</given-names></name><name><surname>Hailey</surname><given-names>H.</given-names></name><name><surname>Williams</surname><given-names>J. H. G.</given-names></name><name><surname>Moore</surname><given-names>S. J.</given-names></name><name><surname>Turnpenny</surname><given-names>P. D.</given-names></name><name><surname>Lloyd</surname><given-names>D. J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Characteristics of fetal anticonvulsant syndrome associated autistic disorder.</article-title>
<source/><italic>Dev. Med. Child Neurol.</italic>
<volume>47</volume>
<fpage>551</fpage>–<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1017/s0012162205001076</pub-id>
<pub-id pub-id-type="pmid">16108456</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasia-Filho</surname><given-names>A. A.</given-names></name><name><surname>Londero</surname><given-names>R. G.</given-names></name><name><surname>Achaval</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Functional activities of the amygdala: an overview.</article-title>
<source/><italic>J. Psychiatry Neurosci.</italic>
<volume>25</volume>
<fpage>14</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="pmid">10721680</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiersen</surname><given-names>A. M.</given-names></name><name><surname>Constantino</surname><given-names>J. N.</given-names></name><name><surname>Volk</surname><given-names>H. E.</given-names></name><name><surname>Todd</surname><given-names>R. D.</given-names></name></person-group> (<year>2007</year>). <article-title>Autistic traits in a population-based ADHD twin sample.</article-title>
<source/><italic>J. Child Psychol. Psychiatry</italic>
<volume>48</volume>
<fpage>464</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.2006.01720.x</pub-id>
<pub-id pub-id-type="pmid">17501727</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Repnikova</surname><given-names>E. A.</given-names></name><name><surname>Lyalin</surname><given-names>D. A.</given-names></name><name><surname>McDonald</surname><given-names>K.</given-names></name><name><surname>Astbury</surname><given-names>C.</given-names></name><name><surname>Hansen-Kiss</surname><given-names>E.</given-names></name><name><surname>Cooley</surname><given-names>L. D.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>CNTN6 copy number variations: uncertain clinical significance in individuals with neurodevelopmental disorders.</article-title>
<source/><italic>Eur. J. Med. Genet.</italic>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2019.02.008</pub-id>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="pmid">30836150</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rio</surname><given-names>M.</given-names></name><name><surname>Royer</surname><given-names>G.</given-names></name><name><surname>Gobin</surname><given-names>S.</given-names></name><name><surname>de Blois</surname><given-names>M.</given-names></name><name><surname>Ozilou</surname><given-names>C.</given-names></name><name><surname>Bernheim</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Monozygotic twins discordant for submicroscopic chromosomal anomalies in 2p25.3 region detected by array CGH.</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>84</volume>
<fpage>31</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1111/cge.12036</pub-id>
<pub-id pub-id-type="pmid">23061379</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Risch</surname><given-names>N.</given-names></name><name><surname>Hoffmann</surname><given-names>T. J.</given-names></name><name><surname>Anderson</surname><given-names>M.</given-names></name><name><surname>Croen</surname><given-names>L. A.</given-names></name><name><surname>Grether</surname><given-names>J. K.</given-names></name><name><surname>Windham</surname><given-names>G. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Familial recurrence of autism spectrum disorder: evaluating genetic and environmental contributions.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>171</volume>
<fpage>1206</fpage>–<lpage>1213</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2014.13101359</pub-id>
<pub-id pub-id-type="pmid">24969362</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>E. B.</given-names></name><name><surname>Lichtenstein</surname><given-names>P.</given-names></name><name><surname>Anckarsäter</surname><given-names>H.</given-names></name><name><surname>Happé</surname><given-names>F.</given-names></name><name><surname>Ronald</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Examining and interpreting the female protective effect against autistic behavior.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>110</volume>
<fpage>5258</fpage>–<lpage>5262</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1211070110</pub-id>
<pub-id pub-id-type="pmid">23431162</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rommelse</surname><given-names>N. N. J.</given-names></name><name><surname>Franke</surname><given-names>B.</given-names></name><name><surname>Geurts</surname><given-names>H. M.</given-names></name><name><surname>Hartman</surname><given-names>C. A.</given-names></name><name><surname>Buitelaar</surname><given-names>J. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder.</article-title>
<source/><italic>Eur. Child Adolesc. Psychiatry</italic>
<volume>19</volume>
<fpage>281</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1007/s00787-010-0092-x</pub-id>
<pub-id pub-id-type="pmid">20148275</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronald</surname><given-names>A.</given-names></name><name><surname>Simonoff</surname><given-names>E.</given-names></name><name><surname>Kuntsi</surname><given-names>J.</given-names></name><name><surname>Asherson</surname><given-names>P.</given-names></name><name><surname>Plomin</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample.</article-title>
<source/><italic>J. Child Psychol. Psychiatry</italic>
<volume>49</volume>
<fpage>535</fpage>–<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.2007.01857.x</pub-id>
<pub-id pub-id-type="pmid">18221348</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Wigler</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of <italic>de novo</italic> mutations in the genetics of autism spectrum disorders.</article-title>
<source/><italic>Nat. Rev. Genet.</italic>
<volume>15</volume>
<fpage>133</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3585</pub-id>
<pub-id pub-id-type="pmid">24430941</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roved</surname><given-names>J.</given-names></name><name><surname>Westerdahl</surname><given-names>H.</given-names></name><name><surname>Hasselquist</surname><given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>Sex differences in immune responses: hormonal effects, antagonistic selection, and evolutionary consequences.</article-title>
<source/><italic>Horm. Behav.</italic>
<volume>88</volume>
<fpage>95</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2016.11.017</pub-id>
<pub-id pub-id-type="pmid">27956226</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saghazadeh</surname><given-names>A.</given-names></name><name><surname>Rezaei</surname><given-names>N.</given-names></name></person-group> (<year>2017</year>). <article-title>Brain-derived neurotrophic factor levels in autism: a systematic review and meta-analysis.</article-title>
<source/><italic>J. Autism Dev. Disord.</italic>
<volume>47</volume>
<fpage>1018</fpage>–<lpage>1029</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-016-3024-x</pub-id>
<pub-id pub-id-type="pmid">28138831</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samaco</surname><given-names>R. C.</given-names></name><name><surname>Hogart</surname><given-names>A.</given-names></name><name><surname>LaSalle</surname><given-names>J. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>14</volume>
<fpage>483</fpage>–<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddi045</pub-id>
<pub-id pub-id-type="pmid">15615769</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandin</surname><given-names>S.</given-names></name><name><surname>Lichtenstein</surname><given-names>P.</given-names></name><name><surname>Kuja-Halkola</surname><given-names>R.</given-names></name><name><surname>Larsson</surname><given-names>H.</given-names></name><name><surname>Hultman</surname><given-names>C. M.</given-names></name><name><surname>Reichenberg</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>The familial risk of autism.</article-title>
<source/><italic>JAMA</italic>
<volume>311</volume>
<fpage>1770</fpage>–<lpage>1777</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2014.4144</pub-id>
<pub-id pub-id-type="pmid">24794370</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarachana</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>R.-C.</given-names></name><name><surname>Hu</surname><given-names>V. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Sex hormones in autism: androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e17116</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0017116</pub-id>
<pub-id pub-id-type="pmid">21359227</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauter</surname><given-names>S.</given-names></name><name><surname>von Beust</surname><given-names>G.</given-names></name><name><surname>Burfeind</surname><given-names>P.</given-names></name><name><surname>Weise</surname><given-names>A.</given-names></name><name><surname>Starke</surname><given-names>H.</given-names></name><name><surname>Liehr</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Autistic disorder and chromosomal mosaicism 46,XY[123]/46,XY,del(20)(pter –&gt; p12.2)[10].</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>120A</volume>
<fpage>533</fpage>–<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.20089</pub-id>
<pub-id pub-id-type="pmid">12884434</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmunk</surname><given-names>G.</given-names></name><name><surname>Gargus</surname><given-names>J. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Channelopathy pathogenesis in autism spectrum disorders.</article-title>
<source/><italic>Front. Genet.</italic>
<volume>4</volume>:<issue>222</issue>. <pub-id pub-id-type="doi">10.3389/fgene.2013.00222</pub-id>
<pub-id pub-id-type="pmid">24204377</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schork</surname><given-names>A. J.</given-names></name><name><surname>Won</surname><given-names>H.</given-names></name><name><surname>Appadurai</surname><given-names>V.</given-names></name><name><surname>Nudel</surname><given-names>R.</given-names></name><name><surname>Gandal</surname><given-names>M.</given-names></name><name><surname>Delaneau</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>A genome-wide association study of shared risk across psychiatric disorders implicates gene regulation during fetal neurodevelopment.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>22</volume>
<fpage>353</fpage>–<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0320-0</pub-id>
<pub-id pub-id-type="pmid">30692689</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroer</surname><given-names>R. J.</given-names></name><name><surname>Phelan</surname><given-names>M. C.</given-names></name><name><surname>Michaelis</surname><given-names>R. C.</given-names></name><name><surname>Crawford</surname><given-names>E. C.</given-names></name><name><surname>Skinner</surname><given-names>S. A.</given-names></name><name><surname>Cuccaro</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Autism and maternally derived aberrations of chromosome 15q.</article-title>
<source/><italic>Am. J. Med. Genet.</italic>
<volume>76</volume>
<fpage>327</fpage>–<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1096-8628(19980401)76:4&lt;327::aid-ajmg8&gt;3.0.co;2-m</pub-id>
<pub-id pub-id-type="pmid">9545097</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>E.</given-names></name><name><surname>Guest</surname><given-names>P. C.</given-names></name><name><surname>Rahmoune</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Levin</surname><given-names>Y.</given-names></name><name><surname>Ingudomnukul</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Sex-specific serum biomarker patterns in adults with Asperger’s syndrome.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>16</volume>
<fpage>1213</fpage>–<lpage>1220</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2010.102</pub-id>
<pub-id pub-id-type="pmid">20877284</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sebat</surname><given-names>J.</given-names></name><name><surname>Lakshmi</surname><given-names>B.</given-names></name><name><surname>Malhotra</surname><given-names>D.</given-names></name><name><surname>Troge</surname><given-names>J.</given-names></name><name><surname>Lese-Martin</surname><given-names>C.</given-names></name><name><surname>Walsh</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Strong association of <italic>De Novo</italic> copy number mutations with autism.</article-title>
<source/><italic>Science</italic>
<volume>316</volume>
<fpage>445</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1126/science.1138659</pub-id>
<pub-id pub-id-type="pmid">17363630</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serajee</surname><given-names>F.</given-names></name><name><surname>Nabi</surname><given-names>R.</given-names></name><name><surname>Zhong</surname><given-names>H.</given-names></name><name><surname>Mahbubul</surname><given-names>H.</given-names></name></person-group> (<year>2003</year>). <article-title>Association of INPP1, PIK3CG, and TSC2 gene variants with autistic disorder: implications for phosphatidylinositol signalling in autism.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>40</volume>:<issue>e119</issue>. <pub-id pub-id-type="doi">10.1136/jmg.40.11.e119</pub-id>
<pub-id pub-id-type="pmid">14627686</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>Y.</given-names></name><name><surname>Cuccaro</surname><given-names>M. L.</given-names></name><name><surname>Hauser</surname><given-names>E. R.</given-names></name><name><surname>Raiford</surname><given-names>K. L.</given-names></name><name><surname>Menold</surname><given-names>M. M.</given-names></name><name><surname>Wolpert</surname><given-names>C. M.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Fine mapping of autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>72</volume>
<fpage>539</fpage>–<lpage>548</lpage>. <pub-id pub-id-type="doi">10.1086/367846</pub-id>
<pub-id pub-id-type="pmid">12567325</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Su</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Sex biased gene expression profiling of human brains at major developmental stages.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>6</volume>:<issue>21181</issue>. <pub-id pub-id-type="doi">10.1038/srep21181</pub-id>
<pub-id pub-id-type="pmid">26880485</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Short</surname><given-names>P. J.</given-names></name><name><surname>McRae</surname><given-names>J. F.</given-names></name><name><surname>Gallone</surname><given-names>G.</given-names></name><name><surname>Sifrim</surname><given-names>A.</given-names></name><name><surname>Won</surname><given-names>H.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title><italic>De novo</italic> mutations in regulatory elements in neurodevelopmental disorders.</article-title>
<source/><italic>Nature</italic>
<volume>555</volume>
<fpage>611</fpage>–<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1038/nature25983</pub-id>
<pub-id pub-id-type="pmid">29562236</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>S. E. P.</given-names></name><name><surname>Zhou</surname><given-names>Y.-D.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Jin</surname><given-names>Z.</given-names></name><name><surname>Stoppel</surname><given-names>D. C.</given-names></name><name><surname>Anderson</surname><given-names>M. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Increased gene dosage of ube3a results in autism traits and decreased glutamate synaptic transmission in mice.</article-title>
<source/><italic>Sci. Transl. Med.</italic>
<volume>3</volume>:<issue>103ra97</issue>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3002627</pub-id>
<pub-id pub-id-type="pmid">21974935</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soltani</surname><given-names>A.</given-names></name><name><surname>Lebrun</surname><given-names>S.</given-names></name><name><surname>Carpentier</surname><given-names>G.</given-names></name><name><surname>Zunino</surname><given-names>G.</given-names></name><name><surname>Chantepie</surname><given-names>S.</given-names></name><name><surname>Maïza</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Increased signaling by the autism-related Engrailed-2 protein enhances dendritic branching and spine density, alters synaptic structural matching, and exaggerates protein synthesis.</article-title>
<source/><italic>PLoS One</italic>
<volume>12</volume>:<issue>e0181350</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0181350</pub-id>
<pub-id pub-id-type="pmid">28809922</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamouli</surname><given-names>S.</given-names></name><name><surname>Anderlid</surname><given-names>B.-M.</given-names></name><name><surname>Willfors</surname><given-names>C.</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B.</given-names></name><name><surname>Wei</surname><given-names>J.</given-names></name><name><surname>Berggren</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Copy number variation analysis of 100 twin pairs enriched for neurodevelopmental disorders.</article-title>
<source/><italic>Twin Res. Hum. Genet.</italic>
<volume>21</volume>
<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1017/thg.2017.69</pub-id>
<pub-id pub-id-type="pmid">29307321</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefansson</surname><given-names>H.</given-names></name><name><surname>Meyer-Lindenberg</surname><given-names>A.</given-names></name><name><surname>Steinberg</surname><given-names>S.</given-names></name><name><surname>Magnusdottir</surname><given-names>B.</given-names></name><name><surname>Morgen</surname><given-names>K.</given-names></name><name><surname>Arnarsdottir</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>CNVs conferring risk of autism or schizophrenia affect cognition in controls.</article-title>
<source/><italic>Nature</italic>
<volume>505</volume>
<fpage>361</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1038/nature12818</pub-id>
<pub-id pub-id-type="pmid">24352232</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stergiakouli</surname><given-names>E.</given-names></name><name><surname>Davey Smith</surname><given-names>G.</given-names></name><name><surname>Martin</surname><given-names>J.</given-names></name><name><surname>Skuse</surname><given-names>D. H.</given-names></name><name><surname>Viechtbauer</surname><given-names>W.</given-names></name><name><surname>Ring</surname><given-names>S. M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Shared genetic influences between dimensional ASD and ADHD symptoms during child and adolescent development.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>8</volume>:<issue>18</issue>. <pub-id pub-id-type="doi">10.1186/s13229-017-0131-2</pub-id>
<pub-id pub-id-type="pmid">28392908</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>D.</given-names></name><name><surname>Cho</surname><given-names>M. T.</given-names></name><name><surname>Chikarmane</surname><given-names>R.</given-names></name><name><surname>Willaert</surname><given-names>R.</given-names></name><name><surname>Retterer</surname><given-names>K.</given-names></name><name><surname>Kendall</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Association of the missense variant p.A<italic>rg</italic>203Trp in PACS1 as a cause of intellectual disability and seizures.</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>92</volume>
<fpage>221</fpage>–<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1111/cge.12956</pub-id>
<pub-id pub-id-type="pmid">28111752</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stessman</surname><given-names>H. A. F.</given-names></name><name><surname>Xiong</surname><given-names>B.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Hoekzema</surname><given-names>K.</given-names></name><name><surname>Fenckova</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Targeted sequencing identifies 91 neurodevelopmental disorder risk genes with autism and developmental disability biases.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>49</volume>
<fpage>515</fpage>–<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3792</pub-id>
<pub-id pub-id-type="pmid">28191889</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stodgell</surname><given-names>C. J.</given-names></name><name><surname>Ingram</surname><given-names>J. L.</given-names></name><name><surname>O’Bara</surname><given-names>M.</given-names></name><name><surname>Tisdale</surname><given-names>B. K.</given-names></name><name><surname>Nau</surname><given-names>H.</given-names></name><name><surname>Rodier</surname><given-names>P. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Induction of the homeotic gene Hoxa1 through valproic acid’s teratogenic mechanism of action.</article-title>
<source/><italic>Neurotoxicol. Teratol.</italic>
<volume>28</volume>
<fpage>617</fpage>–<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2006.08.004</pub-id>
<pub-id pub-id-type="pmid">16989981</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strømme</surname><given-names>P.</given-names></name><name><surname>Mangelsdorf</surname><given-names>M. E.</given-names></name><name><surname>Scheffer</surname><given-names>I. E.</given-names></name><name><surname>Gécz</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Infantile spasms, dystonia, and other X-linked phenotypes caused by mutations in Aristaless related homeobox gene, ARX.</article-title>
<source/><italic>Brain Dev.</italic>
<volume>24</volume>
<fpage>266</fpage>–<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1016/s0387-7604(02)00079-7</pub-id>
<pub-id pub-id-type="pmid">12142061</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>P. F.</given-names></name><name><surname>Magnusson</surname><given-names>C.</given-names></name><name><surname>Reichenberg</surname><given-names>A.</given-names></name><name><surname>Boman</surname><given-names>M.</given-names></name><name><surname>Dalman</surname><given-names>C.</given-names></name><name><surname>Davidson</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Family history of schizophrenia and bipolar disorder as risk factors for autism.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>69</volume>
<fpage>1099</fpage>–<lpage>1103</lpage>. <pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2012.730</pub-id>
<pub-id pub-id-type="pmid">22752149</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Poschmann</surname><given-names>J.</given-names></name><name><surname>Cruz-Herrera del Rosario</surname><given-names>R.</given-names></name><name><surname>Parikshak</surname><given-names>N. N.</given-names></name><name><surname>Hajan</surname><given-names>H. S.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Histone acetylome-wide association study of autism spectrum disorder.</article-title>
<source/><italic>Cell</italic>
<volume>167</volume>
<fpage>1385.e11</fpage>–<lpage>1397.e11</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.10.031</pub-id>
<pub-id pub-id-type="pmid">27863250</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szafranski</surname><given-names>P.</given-names></name><name><surname>Schaaf</surname><given-names>C. P.</given-names></name><name><surname>Person</surname><given-names>R. E.</given-names></name><name><surname>Gibson</surname><given-names>I. B.</given-names></name><name><surname>Xia</surname><given-names>Z.</given-names></name><name><surname>Mahadevan</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Structures and molecular mechanisms for common 15q13.3 <italic>Microduplications</italic> involving CHRNA7: benign or pathological?</article-title>
<source/><italic>Hum. Mutat.</italic>
<volume>31</volume>
<fpage>840</fpage>–<lpage>850</lpage>. <pub-id pub-id-type="doi">10.1002/humu.21284</pub-id>
<pub-id pub-id-type="pmid">20506139</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takuma</surname><given-names>K.</given-names></name><name><surname>Hara</surname><given-names>Y.</given-names></name><name><surname>Kataoka</surname><given-names>S.</given-names></name><name><surname>Kawanai</surname><given-names>T.</given-names></name><name><surname>Maeda</surname><given-names>Y.</given-names></name><name><surname>Watanabe</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism.</article-title>
<source/><italic>Pharmacol. Biochem. Behav.</italic>
<volume>126</volume>
<fpage>43</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2014.08.013</pub-id>
<pub-id pub-id-type="pmid">25240644</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talebizadeh</surname><given-names>Z.</given-names></name><name><surname>Bittel</surname><given-names>D.</given-names></name><name><surname>Miles</surname><given-names>J.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Kibiryeva</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>No association between HOXA1 and HOXB1 genes and autism spectrum disorders (ASD).</article-title>
<source/><italic>J. Med. Genet</italic>.
<volume>39</volume>:<issue>e70</issue>. <pub-id pub-id-type="doi">10.1136/jmg.39.11.e70</pub-id>
<pub-id pub-id-type="pmid">12414832</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>G.</given-names></name><name><surname>Gudsnuk</surname><given-names>K.</given-names></name><name><surname>Kuo</surname><given-names>S.-H.</given-names></name><name><surname>Cotrina</surname><given-names>M. L.</given-names></name><name><surname>Rosoklija</surname><given-names>G.</given-names></name><name><surname>Sosunov</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.</article-title>
<source/><italic>Neuron</italic>
<volume>83</volume>
<fpage>1131</fpage>–<lpage>1143</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.07.040</pub-id>
<pub-id pub-id-type="pmid">25155956</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thapar</surname><given-names>A.</given-names></name><name><surname>Cooper</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Copy number variation: what is it and what has it told us about child psychiatric disorders?</article-title>
<source/><italic>J. Am. Acad. Child Adolesc. Psychiatry</italic>
<volume>52</volume>
<fpage>772</fpage>–<lpage>774</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaac.2013.05.013</pub-id>
<pub-id pub-id-type="pmid">23880486</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>The Autism Genome Project Consortium</surname><given-names>P.</given-names></name><name><surname>Paterson</surname><given-names>A. D.</given-names></name><name><surname>Zwaigenbaum</surname><given-names>L.</given-names></name><name><surname>Roberts</surname><given-names>W.</given-names></name><name><surname>Brian</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Mapping autism risk loci using genetic linkage and chromosomal rearrangements.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>39</volume>
<fpage>319</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1038/ng1985</pub-id>
<pub-id pub-id-type="pmid">17322880</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><collab>The Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium</collab> (<year>2017</year>). <article-title>Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>8</volume>:<issue>21</issue>. <pub-id pub-id-type="doi">10.1186/s13229-017-0137-9</pub-id>
<pub-id pub-id-type="pmid">28540026</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>S. S.</given-names></name><name><surname>Jun</surname><given-names>H.-I.</given-names></name><name><surname>Bahn</surname><given-names>J. H.</given-names></name><name><surname>Azghadi</surname><given-names>A.</given-names></name><name><surname>Ramaswami</surname><given-names>G.</given-names></name><name><surname>Van Nostrand</surname><given-names>E. L.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Widespread RNA editing dysregulation in brains from autistic individuals.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>22</volume>
<fpage>25</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0287-x</pub-id>
<pub-id pub-id-type="pmid">30559470</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>T. N.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Dickel</surname><given-names>D. E.</given-names></name><name><surname>Hoekzema</surname><given-names>K.</given-names></name><name><surname>Nelson</surname><given-names>B. J.</given-names></name><name><surname>Zody</surname><given-names>M. C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Genomic patterns of <italic>de novo</italic> mutation in simplex autism.</article-title>
<source/><italic>Cell</italic>
<volume>171</volume>
<fpage>710.e12</fpage>–<lpage>722.e12</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.08.047</pub-id>
<pub-id pub-id-type="pmid">28965761</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>T. N.</given-names></name><name><surname>Hormozdiari</surname><given-names>F.</given-names></name><name><surname>Duyzend</surname><given-names>M. H.</given-names></name><name><surname>McClymont</surname><given-names>S. A.</given-names></name><name><surname>Hook</surname><given-names>P. W.</given-names></name><name><surname>Iossifov</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Genome sequencing of autism-affected families reveals disruption of putative noncoding regulatory DNA.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>98</volume>
<fpage>58</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2015.11.023</pub-id>
<pub-id pub-id-type="pmid">26749308</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyburczy</surname><given-names>M. E.</given-names></name><name><surname>Jozwiak</surname><given-names>S.</given-names></name><name><surname>Malinowska</surname><given-names>I. A.</given-names></name><name><surname>Chekaluk</surname><given-names>Y.</given-names></name><name><surname>Pugh</surname><given-names>T. J.</given-names></name><name><surname>Wu</surname><given-names>C.-L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>24</volume>
<fpage>1836</fpage>–<lpage>1842</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu597</pub-id>
<pub-id pub-id-type="pmid">25432535</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honk</surname><given-names>J.</given-names></name><name><surname>Schutter</surname><given-names>D. J.</given-names></name><name><surname>Bos</surname><given-names>P. A.</given-names></name><name><surname>Kruijt</surname><given-names>A.-W.</given-names></name><name><surname>Lentjes</surname><given-names>E. G.</given-names></name><name><surname>Baron-Cohen</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Testosterone administration impairs cognitive empathy in women depending on second-to-fourth digit ratio.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>108</volume>
<fpage>3448</fpage>–<lpage>3452</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1011891108</pub-id>
<pub-id pub-id-type="pmid">21300863</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vorstman</surname><given-names>J.</given-names></name><name><surname>van Daalen</surname><given-names>E.</given-names></name><name><surname>Jalali</surname><given-names>G.</given-names></name><name><surname>Schmidt</surname><given-names>E.</given-names></name><name><surname>Pasterkamp</surname><given-names>R.</given-names></name><name><surname>de Jonge</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>A double hit implicates DIAPH3 as an autism risk gene.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>16</volume>
<fpage>442</fpage>–<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2010.26</pub-id>
<pub-id pub-id-type="pmid">20308993</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.-C.</given-names></name><name><surname>Lin</surname><given-names>H.-C.</given-names></name><name><surname>Chan</surname><given-names>Y.-H.</given-names></name><name><surname>Gean</surname><given-names>P.-W.</given-names></name><name><surname>Yang</surname><given-names>Y. K.</given-names></name><name><surname>Chen</surname><given-names>P. S.</given-names></name></person-group> (<year>2013</year>). <article-title>5-HT1A-receptor agonist modified amygdala activity and amygdala-associated social behavior in a valproate-induced rat autism model.</article-title>
<source/><italic>Int. J. Neuropsychopharmacol.</italic>
<volume>16</volume>
<fpage>2027</fpage>–<lpage>2039</lpage>. <pub-id pub-id-type="doi">10.1017/S1461145713000473</pub-id>
<pub-id pub-id-type="pmid">23823694</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Corominas</surname><given-names>R.</given-names></name><name><surname>Lin</surname><given-names>G. N.</given-names></name></person-group> (<year>2019</year>). <article-title><italic>De novo</italic> mutations from whole exome sequencing in neurodevelopmental and psychiatric disorders: from discovery to application.</article-title>
<source/><italic>Front. Genet.</italic>
<volume>10</volume>:<issue>258</issue>. <pub-id pub-id-type="doi">10.3389/fgene.2019.00258</pub-id>
<pub-id pub-id-type="pmid">31001316</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>L. A.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Korn</surname><given-names>J. M.</given-names></name><name><surname>Arking</surname><given-names>D. E.</given-names></name><name><surname>Miller</surname><given-names>D. T.</given-names></name><name><surname>Fossdal</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Association between microdeletion and microduplication at 16p11.2 and Autism.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>358</volume>
<fpage>667</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa075974</pub-id>
<pub-id pub-id-type="pmid">18184952</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenger</surname><given-names>T. L.</given-names></name><name><surname>Kao</surname><given-names>C.</given-names></name><name><surname>McDonald-McGinn</surname><given-names>D. M.</given-names></name><name><surname>Zackai</surname><given-names>E. H.</given-names></name><name><surname>Bailey</surname><given-names>A.</given-names></name><name><surname>Schultz</surname><given-names>R. T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>The role of mGluR copy number variation in genetic and environmental forms of syndromic autism spectrum disorder.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>6</volume>:<issue>19372</issue>. <pub-id pub-id-type="doi">10.1038/srep19372</pub-id>
<pub-id pub-id-type="pmid">26781481</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werling</surname><given-names>D. M.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Sex differences in autism spectrum disorders.</article-title>
<source/><italic>Curr. Opin. Neurol.</italic>
<volume>26</volume>
<fpage>146</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1097/WCO.0b013e32835ee548</pub-id>
<pub-id pub-id-type="pmid">23406909</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werling</surname><given-names>D. M.</given-names></name><name><surname>Parikshak</surname><given-names>N. N.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Gene expression in human brain implicates sexually dimorphic pathways in autism spectrum disorders.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>7</volume>:<issue>10717</issue>. <pub-id pub-id-type="doi">10.1038/ncomms10717</pub-id>
<pub-id pub-id-type="pmid">26892004</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitehouse</surname><given-names>A. J. O.</given-names></name><name><surname>Maybery</surname><given-names>M. T.</given-names></name><name><surname>Hart</surname><given-names>R.</given-names></name><name><surname>Mattes</surname><given-names>E.</given-names></name><name><surname>Newnham</surname><given-names>J. P.</given-names></name><name><surname>Sloboda</surname><given-names>D. M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Fetal androgen exposure and pragmatic language ability of girls in middle childhood: implications for the extreme male-brain theory of autism.</article-title>
<source/><italic>Psychoneuroendocrinology</italic>
<volume>35</volume>
<fpage>1259</fpage>–<lpage>1264</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2010.02.007</pub-id>
<pub-id pub-id-type="pmid">20206450</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>C. A.</given-names></name><name><surname>Driscoll</surname><given-names>D. J.</given-names></name><name><surname>Dagli</surname><given-names>A. I.</given-names></name></person-group> (<year>2010</year>). <article-title>Clinical and genetic aspects of Angelman syndrome.</article-title>
<source/><italic>Genet. Med.</italic>
<volume>12</volume>
<fpage>385</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1097/GIM.0b013e3181def138</pub-id>
<pub-id pub-id-type="pmid">20445456</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>C. C. Y.</given-names></name><name><surname>Meaburn</surname><given-names>E. L.</given-names></name><name><surname>Ronald</surname><given-names>A.</given-names></name><name><surname>Price</surname><given-names>T. S.</given-names></name><name><surname>Jeffries</surname><given-names>A. R.</given-names></name><name><surname>Schalkwyk</surname><given-names>L. C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>19</volume>
<fpage>495</fpage>–<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.41</pub-id>
<pub-id pub-id-type="pmid">23608919</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodbury-Smith</surname><given-names>M.</given-names></name><name><surname>Scherer</surname><given-names>S. W.</given-names></name></person-group> (<year>2018</year>). <article-title>Progress in the genetics of autism spectrum disorder.</article-title>
<source/><italic>Dev. Med. Child Neurol.</italic>
<volume>60</volume>
<fpage>445</fpage>–<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1111/dmcn.13717</pub-id>
<pub-id pub-id-type="pmid">29574884</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Xia</surname><given-names>K.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Excessive UBE3A dosage impairs retinoic acid signaling and synaptic plasticity in autism spectrum disorders.</article-title>
<source/><italic>Cell Res.</italic>
<volume>28</volume>
<fpage>48</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2017.132</pub-id>
<pub-id pub-id-type="pmid">29076503</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>J. J.</given-names></name><name><surname>Berrios</surname><given-names>J.</given-names></name><name><surname>Newbern</surname><given-names>J. M.</given-names></name><name><surname>Snider</surname><given-names>W. D.</given-names></name><name><surname>Philpot</surname><given-names>B. D.</given-names></name><name><surname>Hahn</surname><given-names>K. M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>An autism-linked mutation disables phosphorylation control of UBE3A.</article-title>
<source/><italic>Cell</italic>
<volume>162</volume>
<fpage>795</fpage>–<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.06.045</pub-id>
<pub-id pub-id-type="pmid">26255772</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>J. J.</given-names></name><name><surname>Paranjape</surname><given-names>S. R.</given-names></name><name><surname>Walker</surname><given-names>M. P.</given-names></name><name><surname>Choudhury</surname><given-names>R.</given-names></name><name><surname>Wolter</surname><given-names>J. M.</given-names></name><name><surname>Fragola</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasome.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>292</volume>
<fpage>12503</fpage>–<lpage>12515</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M117.788448</pub-id>
<pub-id pub-id-type="pmid">28559284</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yurov</surname><given-names>Y. B.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Demidova</surname><given-names>I. A.</given-names></name><name><surname>Beresheva</surname><given-names>A. K.</given-names></name><name><surname>Kravetz</surname><given-names>V. S.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Unexplained autism is frequently associated with low-level mosaic aneuploidy.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>44</volume>
<fpage>521</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2007.049312</pub-id>
<pub-id pub-id-type="pmid">17483303</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeldovich</surname><given-names>L.</given-names></name></person-group> (<year>2018</year>). <source/><italic>The Evolution of ‘Autism’ as a Diagnosis, Explained.</italic> Available at: <ext-link ext-link-type="uri" xlink:href="https://www.spectrumnews.org/news/evolution-autism-diagnosis-explained/">https://www.spectrumnews.org/news/evolution-autism-diagnosis-explained/</ext-link>(<comment>accessed December 4, 2018</comment>).</mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Mundo</surname><given-names>E.</given-names></name><name><surname>Macciardi</surname><given-names>F.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Reelin gene alleles and susceptibility to autism spectrum disorders.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>7</volume>
<fpage>1012</fpage>–<lpage>1017</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001124</pub-id>
<pub-id pub-id-type="pmid">12399956</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhubi</surname><given-names>A.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Grayson</surname><given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects.</article-title>
<source/><italic>Int. J. Dev. Neurosci.</italic>
<volume>62</volume>
<fpage>63</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2017.02.003</pub-id>
<pub-id pub-id-type="pmid">28229923</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziats</surname><given-names>M. N.</given-names></name><name><surname>Rennert</surname><given-names>O. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Sex-biased gene expression in the developing brain: implications for autism spectrum disorders.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>4</volume>:<issue>10</issue>. <pub-id pub-id-type="doi">10.1186/2040-2392-4-10</pub-id>
<pub-id pub-id-type="pmid">23651621</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zieminska</surname><given-names>E.</given-names></name><name><surname>Toczylowska</surname><given-names>B.</given-names></name><name><surname>Diamandakis</surname><given-names>D.</given-names></name><name><surname>Hilgier</surname><given-names>W.</given-names></name><name><surname>Filipkowski</surname><given-names>R. K.</given-names></name><name><surname>Polowy</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Glutamate, glutamine and GABA levels in rat brain measured using MRS, HPLC and NMR methods in study of two models of autism.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>11</volume>:<issue>418</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00418</pub-id>
<pub-id pub-id-type="pmid">30505268</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>